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ABSTRACT
Siphonochilus aethiopicus (Schweinf.) B.L. Burtt (Zingiberaceae), commonly known as
wild ginger, is a highly sought after plant for use in traditional medicine in South Africa.
Over-exploitation of this medicinal plant has resulted in regional extinction in the wild.
As a result, there is great interest in the medicinal properties of S. aethiopicus, and as
a plant for small scale cultivation to increase the supply for use in traditional medicine.
Water, ethanol and ethyl acetate extracts were prepared from the leaves, rhizomes and
roots of S. aethiopicus. These extracts were tested for in vitro anti-inflammatory activity
in the cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) assays, and in the
microdilution antibacterial assay.
The aqueous extracts showed no significant prostaglandin synthesis inhibition in the
COX-1 and COX-2 assays. The ethanol and ethyl acetate extracts of the leaves
showed the highest levels of activity at a concentration of 250 ~g ml' per test solution,
in both the COX-1 and COX-2 assays. The ethanol and ethyl acetate extracts of the
rhizomes and roots also had moderate levels of activity in the COX-1 assay. These
results provide some evidence for the rational use of S. aethiopicus in traditional
medicine for anti-inflammatory purposes.
In the microdilution antibacterial assay, no inhibitory activity against the test bacteria
was detected with the aqueous·extracts. The ethanol and ethyl acetate extracts tested
showed greater antibacterial activity at minimal inhibitory concentrations ranging from
0.78 to 3.13 mg ml' against the Gram-positive bacteria (Bacillus subtilis,
Staphylococcus aureus) than the Gram-negative bacteria (Escherichia coli, Klebsiella
pneumoniae). No distinct differences were observed between the ethanol and ethyl
acetate extracts, or between the different plant parts.
A serial extraction of S. aethiopicus rhizome material was conducted and the extracts
were tested in the COX-1 assay and the microdilution assay as a preliminary
investigation for a bulk extraction. The hexane and ethyl acetate extracts gave slightly
higher COX-1 inhibition than the ethanol extract. No distinct differences were observed
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in the microdilution assay.
A bulk ethyl acetate extract of S. aethiopicus rhizome material was prepared , yielding
6.3 g of a thin orange oil. Vacuum liquid chromatography (VLC) was used to fractionate
:::: 4 g of the extract. The VLC fractions were evaluated using thin layer chromatography
(TLC) and a bioautographic assay, using S. aureus as a test organism. The fractions
were also tested in the CQX-1 assay. The bioautography revealed a number of
compounds which exhibited antibacterial activity.
Fraction C was purified further using preparative TLC, and 24.9 mg of a pure compound
from R,0.54 (toluene:ethyl acetate 93:7) was isolated. The structure of the compound
was elucidated from nuclear magnetic resonance (NMR) spectra, and mass
spectroscopy of the compound was also recorded. The compound was identified as the
sesquiterpenoid furanoeremophil-2-en-1-one, which is structurally identical to the
recently reported compound 4aaH-3,5a , 8a~-trimethyl-4,4a,9-tetrahydro-naphtho[2 , 3-b]­
furan-8-one. The compound showed only a very minimal bacteriostatic effect in the
microdilution assay.
S. aethiopicus plants were harvested before and after seasonal senescence. Ethanol
extracts were prepared from fresh or dried material of the leaves, rhizomes and roots,
and tested in the CQX-1 assay and the microdilution assay . TLC fingerprints of the
various extracts were also prepared.
No noteworthy changes in CQX-1 inhibition, due to senescence, were observed with
extracts prepared from fresh material, although there did appear to be a slight decrease
in activity in the a-roots and an increase in the B-roots after senescence (fresh and dry) .
A decrease in the antibacterial activity of the leaves and an increase in the antibacterial
activity of the a-roots was observed after senescence. These results suggest that the
time of harvest may only have a minimal influence on the degree of anti-inflammatory
and antibacterial activity.
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1.1.1 The medicinal value of plants
The recognition of the medicinal value of certain plants seems to have occurred in the
history of all cultures . The sciences of medicine and botany have , for a long time , been
very closely linked . One of the earliest records of the use of plants for medic inal
purposes is found on clay tablets from Mesopotamia , written in cuneiform, and dating
back to about 2600 BC (CRAGG and NEWMAN, 2001). Another ancient reference to
the medicinal use of plants , which dates back to approximately 1550 BC, is found in the
Ebers Papyrus discovered in 1873. In this Egyptian manuscript, some 700 herbal
remedies are described, some of which are familiar today , such as opium and castor oil
(WILLlAMS, 1947; PAGE, CURTIS, SUTTER, WALKER and HOFFMAN, 1997).
Two well developed systems of traditional medicine can be seen in Indian Ayurvedic
medicine and Chinese traditional medicine, which have been extensively documented
over centuries (CRAGG and NEWMAN, 2001) . In the Indian system of Ayurvedic
medicine, which has been in practice for centuries, about 2400 plant species are used
for the treatment of human ailments . The properties and preparations of Indian
medicinal plants have been well documented by ancient Indian scholars (BHAKUNI,
1986). The use of many crude plant extracts for the treatment of a wide range of
ailments is also documented in well-respected pharmacopoeias, such as the European
Pharmacopoeia and the United States Pharmacopoeia.
There are a number of well-known plants which have provided medical science with
significant discoveries. Two highly valuable drugs for leukaemia chemotherapy were
isolated from Catharanthus roseus (Madagascar periwinkle). Vinblastine is effective in
the treatment of Hodgkins disease, and vincristine is a particularly effective treatment
for leukaemia in children (ADDAE-MENSAH, 1992). Another well-known example is the
isolation of digitoxin from Digitalis purpurea, the common purple foxglove , for the
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treatment of certa in kinds of heart disease. Many other examples of plant-derived drugs
include aspir in, atropine, bulbocapnine, cocaine , codeine , colchicine , ephedrine ,
hyoscyamine, ipecac, morphine , papaverine, physost igmine, picrotoxin, pilocarpine ,
pseudoephedrine, quinidine , reserpine, scopolamine, strychnine , theophylline and d-
tubocurarine (COX and BALlCK, 1994; COX, 1995). A more recent example is taxo l,
a taxane diterpenoid from Taxus brevifolia (Pacific yew),which is used for the treatment
of ovarian cancer (BALANDRIN , KINGHORN and FARNSWORTH , 1993).
1.1.2 Drug development from plants
The process of extracting and isolating active chemicals from plants forms an important
part of modern drug development. In 1805 SertClrner isolated the first pure drug ,
morphine (PAGE, CURTIS , SUTTER, WALKER and HOFFMAN , 1997), and in 1820
Caventou and Pelletier reported the isolation of quinine from the bark of Cinchona, for
the treatment of malaria (CRAGG and NEWMAN, 2001) . These early examples of the
isolation of plant-derived drugs greatly extended this branch of science during the 19th
century , and in recent years , we have seen an even greater expansion of research in
the fields of phytochemistry, pharmacognosy and the study of medicinal plants. The
field of pharmacognosy deals with studies of the chemistry of natural product drugs and
has evolved from being a descriptive botanical subject to one having a more chemical
and biological focus (KINGHORN, 2001) .
The isolation of pure substances for pharmacological testing is often more desirable
than the use of crude extracts , because the use of medicinal plants in their natural state
can present several difficulties (PAGE, CURTIS , SUTIER, WALKER and HOFFMAN,
1997). The content of the active constituents may vary with geographic locality, climat ic
and ecological conditions. The time of harvest and seasonal variation may also play an
important role. Furthermore, the efficacy of raw plant material may deteriorate because
of various collection, storage and preparation factors (COLEGATE and MOLYNEUX,
1993). The isolation of pure substances thus has the advantage that the administrat ion
of effective doses can be more accurate.
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Another advantage to the extraction and isolation of a useful plant chemical is that the
compound can be identified. From this identification, it may be possible to develop an
economical synthesis of the chemical, thus avoiding the dependence on the plant as a
source for the drug. Furthermore, chemists can gain valuable information from isolated
natural products which could provide clues to structure/activity relationships and the
design and development of novel drug compounds (COLEGATE and MOLYNEUX,
1993). It may also be possible to develop a drug with less side effects or improved
efficacy. This is usually done through the chemical modification of biologically active
substances (WILLlAMS, 1947). An example of this is the well-known, and probably
most widely used drug, aspirin. Aspirin is a more effective analgesic and anti-pyretic
drug from the synthetic acetyl derivative of salicylic acid, which occurs naturally in the
bark of willow (Salix alba) and poplar (WILLlAMS, 1947).
Although modern chemistry has allowed for the development of many synthetic drugs,
drugs and drug derivatives from plants still find extensive and increasing use. Natural
products and their derivatives represent more than 50% of all drugs in clinical use in the
world, with higher plants contributing about 25% to the total (CRAGG, NEWMAN and
SNADER, 1997). Furthermore, BALANDRIN, KINGHORN and FARNSWORTH (1993)
estimate that at least 85% of the world's estimated 250 000 species of higher plants
have not been adequately surveyed for potentially useful biological activity. Many plant
secondary metabolites are genus or species specific, and as a result, the chances of
discovering new biologically active plant constituents are promising.
It is important to consider that the development of a clinical drug from a natural product
is a formidable challenge and includes various hurdles such as toxicology,
pharmacokinetics and metabolism studies. Few of the compounds which exhibit activity
in laboratory tests become new drugs. Nevertheless, the discovery of biological activity
and the subsequent isolation of the active principles are necessary first steps in the drug
development process (COX and BALlCK, 1994).
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1.2 ETHNOBOTANY
1.2.1 Ethnobotanical approach to drug discovery
Drug discovery is generally based on three principal approaches: (1) the modification
of structures of a known drug; (2) random screening; and (3) the synthesis of
substances based on the knowledge of the biological process with which it is to interfere
(LAURENCE and BENNETT, 1980). However, the incorporation of the information
gained from traditional medicine and plant usage can greatly enhance the chances of
discovering phytochemicals which may be medicinally useful. Ethnobotanical findings
can be used for targeting plant materials in a more meaningful way, instead of relying
on random screening procedures.
Ethnobotany is a broad term which refers to the study of plants by people, and
encompasses the use of plants as foods, medicines, building materials or for other
economicapplications. Ethnomedicine (or ethnobotanical medicine) is a term which is
used to refer to the use of plants by people for medicinal purposes (FARNSWORTH,
1994).
The ethnobotanical approach to drug discovery combines the analysis of indigenous
knowledge and bioassay-guided evaluation of medicinally used plants (COX, 1995).
Exploring the medicinal uses of plants by indigenous peoples and obtaining information
of which plants are used in traditional medicine, how they are used, and for which
ailments, potentially increases the chances for the discovery of novel therapeutic
agents. This method of plant selection, based on their use in traditional medicine, has
already provided a number of well-established drugs. FABRICANTand FARNSWORTH
(2001) list 122 drugs from 94 plant species which have been discovered from
ethnobotanical leads.
As discussed earlier, plants have long been used for various medicinal purposes by
many cultures. The indigenous knowledge of the use of plants is often passed on orally
from one generation to another, and in some cultures, through various written forms.
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There is much concern that the loss of endemic cultures in many parts of the world , due
to increased influence of other cultures , will result in the loss of empirical ethnobotanical
knowledge that has been acquired over thousands of years (COLEGATE and
MOLYNEUX, 1993). As a result , research in ethnobotanical medicine , the biological
activity of medicinal plants and the active chemical principles have received renewed
interest in recent years .
1.2.2 Traditional medicine in South Africa
In many developing countries traditional herbal remedies and traditional medicine play
a major role in the health care of the people. As a result , the World Health Organization
has estimated that 80% of the world's population rely on traditional medicine for their
primary health care needs (FARNSWORTH, 1994). In such countries , most prescription
medicines are either inaccessible, too expensive or not readily accepted by the people
from a cultural perspective (VAN STADEN, 1999).
In South Africa, indigenous or traditional medicine forms an integral part of the culture
and health care of many people. A report by MANDER (1998) on the trade of
indigenous medicinal plants in KwaZulu-Natal, has estimated that there are some 27
million consumers of indigenous medicines in South Africa, and over 700 plant species
which are actively traded. According to VAN WYK, VAN OUDTSHOORN and GERICKE
(1997) approximately 3000 South African plants are used as medicines, with some 350
species being commonly used and traded as medicines.
In recent times, there has been a shift in traditional medicine, where not only the
traditional herbalists (izinyanga) and the diviners (izangoma) are involved in the trade
of medicinal plants . There is now an extensive trade network related to the sale of
medicinal plants in rural and urban areas . Key components of this network include
collectors, transporters , hawkers , wholesalers , retailers and traditional healers
(MANDER, MANDER and BREEN, 1996). Many commercial gatherers, mostly women,
also sell medicinal plant material at informal markets or supply formal-sector traders.
Many of these gatherers know little about traditional healing and the sustainability of the
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plant resources, but collect plants to generate income. Furthermore, most plant
products are sold in the raw form, with little processing of the plants (CUNNINGHAM,
1991; VAN STADEN, 1999).
There has been an increased focus in recent years in ethnobotanical research and the
. study of medicinal plants. Part of the increased attention to this field in South Africa has
been as a result of an understanding that there is a lack of detailed documentation on
the use of medicinal plants, and the increased pressure for conservation (VAN WYK,
I
VAN OUDTSHOORN and GERICKE, 1997). Most ethnobotanical knowledge is derived
from traditional healers, whose understanding and knowledge of rnedicinat plants has
been passed down orally through many generations. With rapid urbanisation, there is
I
an increasing threat that much of this information will disappear (FABRICANT and
FARNSWORTH,2001).
1.2.3 Conservation of medicinal plants
Traditional healers are more numerous and more accessible than western doctors in
most rural areas (CUNNINGHAM, 1988a). Furthermore, the demand for traditional
medicine is considerably higher relative to the demand for western health care services ,
even in urban areas. There is therefore a great demand for medicinal plants in terms
of number and the mass of plants used because traditional medicine is based almost
entirely on the use of indigenous plants, which are collected from wild plant stocks
(MANDER, 1998).
As is the case in many other countries, the harvesting of these wild stocks is not well
managed in South Africa, and little cultivation takes place (MANDER, 1998). This high
demand for popular plant species used for traditional medicine, and unrestricted
collection, has resulted in the extinction of some species outside of protected areas, and
the large scale decline of other species. Many of the most popular medicinal plants are
slow-qrowinq forest trees, from which bark is often destructively harvested, and bulbous
and tuberous plants which are removed entirely. For example Siphonochilus
aethiopicus (wild ginger) is now considered to be regionally extinct in KwaZulu-Natal and
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is a protected species . Other protected species include Ocotea bullata (black
stinkwood) and Warburgia salutaris (pepper bark tree) (SCOTT-SHAW, 1999). There
is therefore an increasing need for conservation of many medicinal plant species
through sustainable use of wild populations and enhanced supply through cultivation
(MANDER, MANDER and BREEN , 1996).
The cultivation of medicinal plants, as suggested by MANDER, MANDER and BREEN
(1996) and CUNNINGHAM (1988b), is one way in which to alleviate the intensive
harvest ing of wild stocks , and reduce the impact on biodiversity. However, for this to be
successful there is a need for the development of greater understanding with respect
to the cultivation and economics of producing useful indigenous plants (MANDER,
MANDER and BREEN , 1996). Cultivation protocols and harvesting regimes for the
different species need to be determined for successful cultivation of medicinal plants.
The cultivation of important medicinal plant species byfarmers, gatherers and traditional
healers is an important strategy for the conservation of endangered species . Th is would
fulfil two functions, providing a means of employment and income , and an alternative
source of medicinal plants which are in high demand (CUNNINGHAM, 1991). The
propagation of medicinal plants by traditional healers and small scale farmers is
receiving increasing attention and has the potential to alleviate some of the pressure on
wild populations (JAGER and VAN STADEN , 2000) .
The possibility of plant substitution or plant-part subst itution is a further means of
alleviating the pressure placed on highly popular medicinal plants . ZSCHOCKE, RABE,
TAYLOR, JAGER and VAN STADEN (2000) conducted a study to investigate the use
of plant part substitution (i.e. the use of leaves instead of bark or underground parts) as
a means of conservation through sustainable harvesting.
A further study by ZSCHOCKE and VAN STADEN (2000) was conducted on
Cryptocarya species, the bark of which is used by traditional healers as an alternative
to the very scarce Ocotea bullata (black stinkwood) bark. Results suggested that it may
be possible to select alternative plant species to substitute for highly endangered
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species . However, this is highly plant specific and would require the evaluation of any
differences or similarities of chemical and pharmacological properties of the different
plant parts. A further important aspect is that the traditional healers using the plants
would need to be encouraged to use leaves or twigs instead of underground parts or
bark, or use alternative plants (ZSCHOCKE , RASE, TAYLOR , JAGER and VAN
STADEN,2000).
1.3 SIPHONOCHILUS AETHIOPICUS
Siphonochilus aethiopicus (Schweinf.) S.L. Surtt, commonly known as wild ginger or
Natal ginger, belongs to the monocotyledonous family Zingiberaceae (tribe Hedychieae).
There has been some taxonomic confusion with the species S. aethiopicus and S.
natalensis, however SMITH (1998) considers these two species to be synonymous.
Synonyms of the species, as listed in the most recent taxonomic treatment, are
Cienkowskia aethiopica Schweinf. , Kaempferia aethiopica (Schweinf.) Senth., K. ethelae
J.M.Wood , K. natalensis (Schlecht. and K.Schum.) , Siphonochilus natalensis (Schlecht.
and K.Schum .) J.M.Wood and Franks and Cienkowskiella aethiopica (Schweinf.)
Y.K.Yam (SMITH , 1998). The plant is used extensively in tradit ional medicine in South
Africa, and was therefore chosen as the focus for this investigation.
1.3.1 The Zingiberaceae
The Zingiberaceae is a family well known for its spice plants, including real ginger,
Zingiber officinale; cardamom, Elletaria cardamomum; and turmeric, Curcuma longa.
The exotic garden ginger Hedychium is another well known member of the
Zingiberaceae. The species are usually caulescent aromatic herbs with thickened
rhizomes and secretory cells with volatile oils (HUTCHINGS, SCOTT, LEWIS and
CUNNINGHAM, 1996). Over 40 genera and about 1300 species are found in the
Zingiberaceae. They occur mainly in the tropics of the Old World (Indomalasia), with
some representatives in South and Central America (SMITH, 1998).
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Many members of the Zingiberaceae are used in tradit ional medicine around the world.
The CRC Ethnobotany Desk Reference (JOHNSON , 1999) documents over 100
different species of the Zingiberaceae which are used for a variety of medicinal
purposes (see Appendix 1). There have been a number of investigations into the
biological properties of many of these species , and the isolation of biologically active
constituents.
1.3.1.1 Zingiberaceae: Anti-inflammatory activity
A variety of compounds which demonstrate anti-inflammatory activity have been isolated
from a number of species of the Zingiberaceae. Hot aqueous extracts from the
rhizomes of Zingiber officinale and Alpinia officinarum were investigated for their action
against PG synthetase and 5-lipoxygenase, with gingerols and diarylheptanoids being
identified as active compounds. The most active compound against PG synthetase was
yakuchinone A, a diarylheptanoid from the fruit of A. officinarum, with an ICso less than
1 urn (KIUCHI , IWAKAMI, SHIBUYA, HANAOKA and SANKAWA, 1992).
CLAESON , PANTHONG, TUCHINoA, REUTRAKUL, KANJANOPOTHI , TAYLOR and
SANTISUK (1993) isolated three non-phenolic diarylheptanoids from hexane extracts
of the rhizomes of Curcuma xanthorrhiza . These compounds showed significant anti-
inflammatory activity in the assay of carrageenin-induced hind paw oedema in rats.
Bioassay-guided fractionation of extracts of the rhizomes of Zingiber cassumunar led
to the isolation of three cassumunins with anti-inflammatory activity (MASUoA and
JITOE, 1994). In further studies on Z. cassumunarby PONGPRAYOON , TUCHINoA,
CLAESON , SEMATONG, REUTRAKUL and SOONTORNSARATUNE (1996), five
compounds with topical anti-inflammatory activity were isolated from hexane extracts
of the rhizome . These compounds gave 1050 values ranging from 2 to 62 I-lg/ear in the
model of 12-0-tetradecanoylphorbol-13-acetate (TPA) induced ear oedema in rats.
Two pimarane diterpenes have been isolated from Kaempferia pulchra, and were found
to have 1050 values estimated at 330 and 50 I-lg/ear in the TPA induced rat ear oedema
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bioassay(SEMATONG, REUTRAKUL, TUCHINOA, CLAESON, PONGPRAYOON and
NAHAR,1996).
Investigations on the constituents of the red rhizome variety of Boesenbergia pandurata
yielded two cyclohexenyl chalcone derivatives which showed significant anti-
inflammatory activity in the TPA induced rat ear oedema bioassay. The 1050 values of
(-)-hydroxypanduratin A and (-)-panduratin A were determined as 84 and 12 IJg/ear,
respectively (TUCHINOA, REUTRAKUL, CLAESON, PONGPRAYOON, SEMATONG,
SANTISUK and TAYLOR, 2002).
1.3.1.2 Zingiberaceae: Antibacterial activity
Antibacterial activity has been shown for a number of species of the Zingiberaceae. In
a study by AHMAO, MEHMOOO and MOHAMMAO (1998), wherein 82 Indian medicinal
plants were screened for antimicrobial properties, alcoholic extracts of the rhizomes of
Curcuma longa showed activity against Bacillus subtilis and Staphylococcus aureus.
Hexane extracts of the seeds of Elettaria cardamomum showed activity against B.
subtilis, Escherichia coli and S. aureus, and alcoholic extracts showed activity against
B. subtilis, E. coli, Proteus vulgaris, Salmonella typhimurium, Pseudomonas aeruginosa,
and S. aureus. In the same study hexane and alcoholic extracts of Zingiber officinale ,
real ginger, showed antibacterial activity against B. subtilis and S. aureus.
The essential oil composition and antibacterial activity of oil from the seeds of
Aframomum citratumwas investigated in a study of the correlation between the chemical
composition and antimicrobial activity of some African essential oils. The seed oil
showed activity against E. coli, Klebsiella pneumoniae, Proteus mirabilis and S. aureus
(CHALCHAT, GARRY, MENUT, LAMATY, MALHURET and CHOPINEAU, 1997).
The antibacterial activity of the fruit of Aframomum melegueta was studied by OLOKE,
KOLAWOLE and ERHUN (1988). Volatile oils from the fruit pod and seeds and solvent
extracts of the seeds were tested against a range of bacteria and showed activity
against B. subtilis , E. coli, K. pneumoniae, P. vulgaris, P. aeruginosa, Pseudomonas
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fluorescens, Serratia marcescens, S. aureus and Yersinia enterocolitica.
The essential oils of Kaempheria ga/anga root and rhizome showed activity against E.
coli and S. aureus (ARAMBEWELA, PERERA and WIJESUNDERA, 1999). In
screening 13 species of Alpinia, Costus and Zingiber, most of the dichloromethane and
methanol extracts showed some antibacterial activity against B. subtilis, methicillin-
resistant S. aureus (MRSA) and P. aeruginosa . The strongest inhibitory activity of a
dichloromethane extract was shown by Alpinia mutica with the minimum inhibitory dose
of 125 IJg per disc against both B. subtilis and MRSA (HABSAH, AMRAN , MACKEEN,
LAJIS, KIKUZAKI, NAKATANI, RAHMAN and GHAFAR, 2000). Essential oils from
fresh and dried rhizomes of Alpinia ga/anga also showed antibacterial activity against
B. subtilis and S. aureus (JANSSEN and SCHEFFER, 1985).
The essential oil composition and antimicrobial activity of three Zingiberaceae species
widely used as medicinal plants from S. Tome e Principe were studied by MARTINS,
SALGUEIRO, GON<;ALVES, PROEN<;A DA CUNHA, VILA, CANIGUERAL, MAZZONI,
TOMI and CASANOVA (2001). The fruit of Aframomum danielli showed antibacterial
activity in the agar diffusion assay against E. coli, S. eureus, Staphylococcus epidermis,
Streptococcus faecalis and P. vulgaris. The zone diameter of inhibition of 15 IJI of oil
per disc ranged from 13 -19 mm. The oils of C. longa and Z. officinale also showed
antibacterial activity against these bacteria. The oil of Z. officinale showed the most
significant activity against P. vulgaris with an inhibition zone of 36 mm.
The hydrodistilled essential oil from the leaves of Aframomum stipulatum, used as a
medicinal plant in the Democratic Republic of Congo, showed antibacterial activity
against a variety of bacteria in the agar diffusion assay. The zone diameter of inhibition
of 5 IJI of oil per disc ranged from 10 -17 mm against B. sub tilis , Citrobactersp., E. coli,
K. pneumoniae, P. vulgaris, P. aeruginosa, S. typhimurium, Shigella flexneri and S.
aureus (CIMANGA, KAMBU, TONA, APERS, DE BRUYNE, HERMANS, TOTTE,
PIETERS and VLlETINCK, 2002).
Members of the Zingiberaceae have also yielded novel compounds with antibacterial
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activity. In phytochemical studies of Amomum aculeatum, two new minor compounds
showing antibacterial activity were isolated from petroleum ether extracts of the rhizome.
The first compound, a dioxa-dispiroketal, gave MIC values of 16, 16 and 8 IJg mr
against Bacillus cereus, E.coli and S. epidermis, respectively. The second compound,
an alkenone, gave MIC values of 32, 64 and 16 IJg rnl' against the same range of
organisms (HEILMANN, BRUN, MAYR, RALI and STICHER, 2001).
1.3.2 Distribution and habitat of S. aethiopicus
S. aethiopicus is widely distributed throughout Africa, occurring southwards from
Senegal and Ethiopia to the northern and eastern parts of South Africa (GORDON-
GRAY, CUNNINGHAM and NICHOLS, 1989). It is the only member of the
Zingiberaceae that is indigenous to South Africa (MAKHUVHA, VAN WYK, VAN DER
BANK and VAN DER BANK, 1997), although three species of Hedychium and Alpinia
zerumbet have become naturalised in certain areas (SMITH, 1998). S. aethiopicus
grows in savanna and coastal grasslands, and in the ecotone of forests and bush
clumps in damp and partially shady sites (ONDERSTALL, 1978; SCOTT-SHAW, 1999).
In South Africa, it has a restricted distribution In Mpumalanga and the Northern
Province, and has become regionally extinct In KwaZulu-Natal as a result of
overexploitation (MANDER, 1998; SCOTT-SHAW, 1999). It was known to have
occurred at Ngoye, Inanda, Dumisa and Umbambasa (Port Shepstone area) and near
Lusikisiki in Pondoland (SCOTT-SHAW, 1999). In a survey conducted by WILLlAMS
(1996), medicinal plant traders in the Witwatersrand area recognised the scarcity of the
plants and regarded S. aethiopicus to be in short supply.
1.3.3 Morphology and reproductive biology of S. aethiopicus
S. aethiopicus is a perennial herb with large, erect, hairless leaves which develop
annually from small cone-shaped rhizomes. The rhizomes are segmented and fleshy,
and narrowly elongate tubers are present on the fibrous roots (Figure 1.1). The crushed
rhizome and roots yield a pungent scent similar to that of real ginger, Zingiberofficinale.
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Between 4 and 8 leaves develop on an unbranched false stem up to 60 cm tall during
or after flowering (GORDON-GRAY, CUNNINGHAM and NICHOLS, 1989; SMITH,
1998). Flowers are borne separately from the leafy shoot, and appear at ground level
in early summer, from the end of October to early December, usually just as the leaves
start to appear. They are broadly funnel-shaped, pink-purple and white in colour with
a small yellow patch in the throat. Most plants are bisexual, and have larger flowers
than female plants (GORDON-GRAY, CUNNINGHAM and NICHOLS, 1989).
Figure 1.1 (A) S. aethiopicus plants with female flowers . (B) S. aethiopicus plant
showing (a) rhizome from the previous year (a-rhizome); (b) current
season rhizome segment (~-rhizome); (c) fleshy roots with small tubers:
(d) female flowers; and (e) leaves.
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This inconsistent polygamous production of hermaphroditic and female flowers,
sometimes on the same rhizome (WOOD and FRANKS, 1911) has partly caused the
confusion of the taxonomy of the species. Although as many as 20 flowers can develop
from one plant, only one flower is fully open at a time and lasts for only one day
(ONDERSTALL, 1978). Small, berry-like fruits are borne below or above the ground
(GORDON-GRAY, CUNNINGHAM and NICHOLS, 1989).
Generally, little is known regarding the population biology of S. aethiopicus, however,
GORDON-GRAY, CUNNINGHAM and NICHOLS (1989) have investigated some
aspects of the floral and reproductive biology of the plant. The complete reproductive
cycle is known for rhizomes that produce bisexual flowers, and details of the vegetative
organs, flowering and growth cycle also apply to rhizomes that produce female flowers.
The rhizomes of S. aethiopicus grow either on the soil surface, or underground to a
depth of 150 mm. During winter, no above ground parts are visible, but with the
beginning of the spring rains the aerial shoots develop. These shoots continue to
elongate after flowering, but growth gradually ceases after the December solstice.
Yellowing of the leaves occurs quite quicky, usually during April, and by May the aerial
parts have fully senesced (GORDON-GRAY, CUNNINGHAM and NICHOLS, 1989).
1.3.4 Volatile oils of S. eethiopicus
Volatile oils are generally used as medicines for their decongestant, antiseptic and
diuretic effects (SRUNETON, 1995). It has been suggested that the monoterpenoids
and sesquiterpenoids in the volatile oils in S. aethiopicus are responsible for the
reported benefits against cough, colds and influenza (HUTCHINGS, 1989; VAN WYK,
VAN OUDTSHOORN and GERICKE, 1997). However, anti-inflammatory activity has
also been shown to be present in extracts of S. aethiopicus (McGAW, JAGER and VAN
STADEN, 1997; L1NDSEY, JAGER, RAIDOO and VAN STADEN, 1999; ZSCHOCKE,
RASE, TAYLOR, JAGER and VAN STADEN, 2000).
In a study of the hydrodistilled essential oils of the roots and rhizomes of S. aethiopicus,
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VILJOEN, DEMIRCI, BASER and VAN WYK (2002) identified 70 compounds in the root
oil (representing 88% of the total oil compos ition) and 60 compounds in the rhizome oil
(88% of total composition) using GC and GC-MS. The essential oils of the roots and
rhizomes were very similar in composition , and showed only minor quantitative
variations. However, none of the terpenoids of the oil of real ginger are present in the
essential oil of S. aethiopicus.
The root and rhizome oils contain high quantities of a novel furanoterpenoid, 4aaH-
3 ,5a,8a~-trimethyl-4,4a,9-tetrahydro-naphtho[2,3-b]-furan-8-one, which represents
approximately 20% of the oils (VILJOEN, DEMIRCI, BASER and VAN WYK , 2002;
HOLZAPFEL, MARAIS, WESSELS and VAN WYK , 2002). Other major compounds in
the oils are 1,8-cineole, (E)-~-ocimene and cis-alloocimene.
1.3.5 Medicinal uses of S. aethiopicus
S. aethiopicus is known in Zulu as indungulo/indungulu (WOOD and FRANKS, 1911)
or isiphephetho (CUNNINGHAM, 1988b). Generally, the rhizome is dug up and used
in traditional medicine (VAN WYK, VAN OUDTSHOORN and GERICKE , 1997). The
rhizomes which are harvested during the growing season have roots on them which are
also used. However, rhizomes which are harvested during the dormant period are
leafless and do not have any roots. Usually, a mixture of crushed rhizomes and roots
is drunk to relieve various ailments, or the rhizomes may also be chewed .
S. aethiopicus has been reported to be used for various respiratory ailments , febrile
complaints, as well as nervous ailments (HUTCHINGS, 1989). It is also sometimes used
as a charm for protection against snakes and lightening , or may be given to horses as
prophylactics against horse sickness (WOOD and FRANKS, 1911; WATT and
BREYER-BRANDWIJK, 1962; SMITH, 1998). Respiratory ailments include asthma ,
chest pain, coughs and sore throats. Febrile complaints include influenza , colds and
fevers, including malaria and rheumatic fever (WATT and BREYER-BRANDWIJK,
1962). Nervous or psychological ailments include such things as hysteria, mental
disturbance and nightmares. Other traditional uses include the treatment of
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dysmenorrhoea (menstrual pain), pain, toothache, rheumatism and neuralgia (WATT
and BREYER-BRANDWIJK, 1962; MANDER , MANDER, CROUCH , McKEAN and
NICHOLS, 1995).
The use of S. aethiop icus for pain relief and inflammation has been supported through
investigations into the inhibitory action against prostaglandin synthesis (McGAW,
JAGER and VAN STADEN , 1997; L1NDSEY, JAGER, RAIDOO and VAN STADEN ,
1999; ZSCHOCKE, RABE, TAYLOR, JAGER and VAN STADEN , 2000). However ,
little is known about other pharmacological properties, and whether there is any
seasonal influence on the levels of activity in S. aethiopicus. It is possible that plant
material of different ages, or harvested at different times , may have varying levels of
biological activity.
1.3.6 Popularity and trade of S. aethiopicus
In a report on the marketing of medicinal plants in KwaZulu-Natal , MANDER (1998)
gives the trading (retail) price for S. aethiopicus as high as R450/kg, making it one of the
most expensive plant products per kg. From the survey conducted , MANDER (1998)
showed that 1.9 t of the plant was traded annually in the Durban Medicinal Trade. On
a weight basis, S. aethiopicus ranked 9th of the popular species being sold. It was also
frequently demanded by consumers, and ranked 8th according to the number of traders
who identified the plants as important (MANDER , 1998).
1.3.7 Propagation and cultivation of S. aethiopicus
As mentioned earlier , S. aethiopicus has received the status of being regionally extinct
in KwaZulu-Natal (SCOTT-SHAW, 1999). However , in recent years there has been
significant interest in cultivating the plant , and successful attempts have been made at
propagating S. aethiopicus on a small scale (HUTCHINGS, SCOTT, LEWIS and
CUNNINGHAM , 1996; VAN WYK and GERICKE, 2000). Cultivation studies have been
conducted to investigate the effect of propagule size, density and soil type on the yield




s. aethiopicus is easily cultivated in the warmer parts of South Africa and large-scale
production through tissue culture is possible (CROUCH and SYMMONDS, 2002).
Furthermore, vegetative propagation, through rhizome division (simple splitting or
longitudinal division), is a very efficient way of propagating S. aethiopicus as fruit set is
generally poor, and seed are difficult to find (NICHOLS, 1989; CROUCH and
SYMMONDS, 2002).
1.4 AIMS AND OBJECTIVES
Medicinal plant research is diverse and often involves a multi-disciplinary approach.
CAVE (1986) describes the goals of research in this field as being (1) the identification
of the active principles of medicinal plants (i.e. plants that "posess pharmacological
activities of possible therapeutic use"), and the investigation of the extracts to ensure
safety, effectiveness and constant activity; and (2) the isolation of the active principles
and the determination of their structure, in order for synthetic development and
structural modifications.
The aims of this study were to:
Screen extracts of S. aethiopicus for anti-inflammatory and antibacterial activity;
Investigate seasonal variation in anti-inflammatory and antibacterial activity;
Investigate the effects of the state of plant material (fresh or dried) on anti-
inflammatory and antibacterial activity; and
Attempt to isolate and identify compounds exhibiting anti-inflammatory and/or
. antibacterial activity.
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2 Investigation of Anti-inflammatory Activity
2.1 INTRODUCTION
2.1.1 Anti-inflammatory agents
Inflammation of living animal tissues occurs as a response to various kinds of "injuries".
It involves a complex combination of effects such as enzyme activation, mediator
release , extravasation of fluid , cell migration, tissue breakdown and repair (VANE and
BOTTING , 1996) . Drugs which are used to suppress inflammatory reactions fall into two
main categories: the glucocorticoids and the non-steroidal anti-inflammatory drugs
(NSAIDs) (RANG and DALE, 1987).
The NSAIDs are among the most widely used of all therapeutic agents and are used for
a variety of musculoskeletal inflammatory conditions and pain. Large quantities of these
drugs, such as aspirin and paracetamol, are bought over the counter for the treatment
of headaches, toothaches and other minor complaints (RANG and DALE, 1987).
NSAIDs include a variety of different compounds from different chemical classes.
Generally, they are classified into the following groups: salicylates (e.g. aspirin ,
diflunisal) ; acetic acids (e.g. indomethacin, diclofenac); propionic acids (e.g. ibuprofen,
naproxen); fenamates (e.g. mefenamic acid, meclofenamate); pyrazoles (e.g.
phenylbutazone); and oxicam (e.g. piroxicam) (MANTRI and WITIAK, 1994).
Most of the NSAIDs have three major types of effects, although not necessarily all to the
same extent. These include the modification of the inflammatory reaction (anti-
inflammatory effect) , the reduction of certain types of pain (analgesic effect), and the
lowering of a raised temperature (antipyretic effect). In general, these effects are all
related to the primary action of the NSAIDs which is the inhibition of cyclooxygenase
(COX) and thus the inhibition of the production of prostaglandins and thromboxanes
(RANG and DALE, 1987). Many of the NSAIDs, however, also have various side effects
in addition to their inhibition of COX. For example, aspirin has a particularly pronounced
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action on platelets (RANG and DALE, 1987).
2.1.2 Prostaglandin pharmacology
The prostaglandins (PGs) and thromboxanes (TXs), along with leukotrienes (LTs), make
up a group of substances known as the eicosanoids. They are implicated in the control
of a wide variety of physiological processes and are among the most important
mediators and modulators of inflammatory reactions (RANG and DALE, 1987). All
mammalian cells, except red blood cells, produce these inflamm~tory mediators, whose
physiological role involves the production of inflammation, pain and fever, the regulation
of blood pressure and the induction of blood clotting (MANTRI and WITIAK, 1994).
The eicosanoids are generated in response to a wide range of stimuli. They are derived
mainly from arachidonic acid (eicosatetraenoic acid) (Figures 2.1 and 2.2), although a
small proportion may be derived from either dihomolinolenic acid or eicosapentaenoic
acid. Arachidonic acid (AA) is present as a triglyceride ester in the phospholipids of cell
membranes (MANTRI and WITIAK, 1994). Through the action of phospholipase A2 (or
phospholipase C and then diacylglycerol lipase), free arachidonic acid is liberated.
Phospholipase A2 action can also give rise to Iyso-glyceryl-phosphorylcholine which is
the precursor of platelet activating factor, another powerful mediator of inflammation
(RANG and DALE, 1987). The free arachidonic acid is metabolised by two main
pathways . The first is by the COX enzyme (prostaglandin H2 [PGH2] synthase) which
initiates the biosynthesis of the prostaglandins (together referred to as the "prostanoids")
and the thromboxanes. The second pathway, by various lipoxygenases (e.g. 5-
lipoxygenase), initiates the synthesis of the leukotrienes, which are of importance as
mediators of asthma (RANG and DALE, 1987; VANE and BaTTING, 1996). A
summary of these pathways is seen in Figure 2.1.
COX is found bound to the endoplasmic reticulum and catalyses the formation of the
cyclic endoperoxides, prostaglandin G2 (PGG2) and prostaglandin H2 (PGH2) (Figure
2.1). This process incorporates both a cyclooxygenase and a peroxidase activity (VANE
and BaTTING, 1996). This dual reaction occurs in almost every cell type in the body,
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but the subsequent steps in the COX metabolic pathway differ depending on the cell
type. This tissue-specificity is as a result of the selective presence of the enzymes
which convert PGH
2
(MANTRI and WITIAK, 1994). In blood platelets the pathway leads
to the synthesis of thromboxane A2 (TXA2) , in vascular endothelium it leads to
prostacyclin (PGI
2
) and in macrophages prostaglandin E2 (PGE2) is mainly synthesized
(RANG and DALE, 1987).
It has been found that the presence of the lipid peroxide enhances the COX activity and
the formation of prostaglandins and thromboxanes. In normal tissue, peroxide levels
are continually reduced by cellular peroxides, thereby limiting the production of
prostanoids. However, in the presence of inflammatory signals, stimulated phagocytic
cells generate superoxide and hydrogen peroxide, increasing the levels of peroxides
which increase the synthesis ofprostanoids (MANTRI and WITIAK, 1994; VANE, 1994).
The prostanoids PGE2, PGI2 , PGF20 and the thromboxane TXA2 are probably the most
important products of the COX pathway (Figures 2.1 and 2.2). Some of the main
actions of the COX metabolites include the vasodilatation of blood vessels, effects on
the aggregation of platelets, vasoconstriction and bronchodilatation in the lungs, and
spasmogenic effects in the uterus. Their role in the production of pain in an area of
inflammation is not a direct one. They have been shown to potentiate the effect of
subthreshold concentrations of other pain-producing mediators such as histamine and
bradykinin (RANG and DALE, 1987; VANE and BOTTING, 1996). Eicosanoids may
also have a role in the pyretic effect of inflammation (i.e. fever) . The antipyretic effect
of NSAIDs is mainly due to their inhibition of the synthesis of PGE1 in the hypothalamus,
as a result of their inhibition of COX (RANG and DALE, 1987). The COX enzyme is
inhibited by three different mechanisms: (1) reversible competitive inhibition; (2)
mechanism based or time-dependent inactivation (irreversible inhibition); and (3)



































Figure 2.1 A schematic representation of the biosynthesis of arachidonic acid
metabolites - prostaglandins and related eicosanoids. PG =
prostaglandin; PGlz = prostacyclin; TX = thromboxane; LT = leukotriene;
HPETE = hyd roperoxyeicosatetraenoic acid ; HETE =


















Figure 2.2 The chemical structures of (A) Arachidonic acid; (B) PGD2 ; (C) PGE2 ;
(D) PGF2a ; and (E) PGI2 0 (From RANG and DALE, 1987).
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2.1.3 Cyclooxygenase enzymes: CQX-1 and CQX-2
The COX enzyme exists in two isoforms, COX-1 and COX-2 (MANTRI and WITIAK,
1994; VANE, 1994). COX-1 is constitutively expressed in most tissues, and is
necessary for the regulation of normal cell activity ("housekeeping") (VANE and
BOTTING, 1996). For example, the production of prostacyclin (PGI2) by the
endothelium provides an antithrombogenic function (VANE, 1994), and in the gastric
mucosa it is cytoprotective (WHITTLE, HIGGS, EAKINS, MONCADA and VANE, 1980).
COX-2, however, is synthesized de novo in a number of cells, such as neutrophils and
mast cells, by inflammatory stimuli (e.g. bacterial endotoxins) and/or cytokines (e.g.
tumor necrosis factor and interleukin 1~) (XIE, ROBERTSON and SIMMONS, 1992).


















Figure 2.3 Actions of the two cyclooxygenase isoforms COX-1 and COX-2. (Adapted
from VANE and BOTTING, 1996).
It has been suggested that the anti-inflammatory action of most NSAIDs is due to the
inhibition of COX-2, and that many of the unwanted side-effects (such as gastric
bleeding and ulceration, reduced platelet aggregation, and toxic effects on the kidney)
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are due to the inhibition of COX-1 (VANE, 1994). The activities of NSAIDs against the
two enzymes differ, ranging from a high selectivity towards COX-1, through to equal
activity (VANE, 1994). For example, NSAIDs such as aspirin and indomethacin are
more potent inhibitors of COX-1 than COX-2 (MEADE, SMITH and DE WITT, 1993).
This range of activities can explain the variation in the side-effects observed with many
NSAIDs.
The difference in activities against COX-1 and COX-2 can be expressed as a ratio of the
IC
50
values. A high ratio indicates more potent inhibition of COX-1. For example, aspirin
and indomethacin have been shown to have COX-1/COX-2 ratios of 166 and 60
respectively (VANE and BOTTING, 1996). However, the published COX-1/COX-2 ratios
can vary according to the test system used and are not ideal for predicting in vivo
activity (VANE and BOTTING, 1996).
In more recent years, there has been increased attention at finding NSAIDs which
selectively inhibit COX-2 only, and do not interfere with COX-1. Compounds which are
selective inhibitors of COX-2 are potentially anti-inflammatory and nonulcerogenic and
would therefore be of considerable interest for therapeutic use (MANTRI and WITIAK,
1994; VANE, 1994). These compounds should have fewer side effects and cause less
gastric irritation. However, in more recent studies, as reviewed by SAUTEBIN (2000),
it seems that the role of COX-1 and COX-2 is more complex than the original hypothesis
which was first put forward. It has also been shown that both COX-1 and COX-2 are
expressed within the normal adult kidney, indicating that COX-2 does not exist purely
as an inducible enzyme (KOMHOFF, GRONE, KLEIN, SEYBERTH and NOSING,
1997).
To date, two highly selective COX-2 inhibitors (Coxibs) have been launched for
therapeutic use: rofecoxib and celecoxib (EMERY, 2001). These two coxibs have been
shown to be safe and effective in the treatment of rheumatoid arthritis, osteoarthritis and
produced no inhibition of gastric mucosa PG production, in contrast to conventional
NSAIDs. Furthermore, thromboxane synthesis and platelet aggregation is not inhibited
by COX-2 inhibitors. However, some of the side effects of NSAIDs are still observed
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with these coxibs , such as fluid retention and dyspepsia (EMERY , 2001 ; SCHNITZER,
2001).
2.1.4 Testing COX inhibition
Plants potentially provide a useful source of new effective anti-inflammatory agents, and
the results gained from preliminary in vitro studies are necessary in order to
subsequently perform targeted in vivo studies. However it should be remembered that
molecules which exhibit good in vitro activity are not always selective in in vivo systems
(SAUTEBIN ,2000). Non-steroidal natural products which have shown inhibition against
COX are found among the flavonoids , phenolic phenylpropane derivatives,
naphthoquinones, alkylamides, diaryl heptane derivatives and tannins (BOHLlN, 1995) .
There are a variety of models which have been developed to test the activity of NSAIDs,
as well as crude plant extracts, for inhibitory action against COX-1 and COX-2. The use
of whole cell systems is an important method which has been developed, because the
penetration of cell membranes is an important aspect of the activity of NSAIDs (VANE
and BOTTING, 1996). However, for the purpose of assessing the relative selectivity of
plant extracts on COX-1 and COX-2, it is often simpler to use purified enzymes or
microsomal preparations in in vitro systems. Furthermore, these type of in vitro
bioassays are advantageous in bioassay-guided fractionation of active extracts where
a large number of fractions need to be tested alOng with phytochemical separation work
(KIUCHI, IWAKAMI , SHIBUYA, HANAOKA and SANKAWA, 1992).
The inhibition of prostaglandin synthesis can be evaluated using an in vitro enzyme
assay adapted from an assay originally described by WHITE and GLASSMAN (1974)
to detect activity of COX. This assay , with various modifications, has been used
extensively for the evaluation of plant extracts . Ovine seminal vesicles are usually used
as a source for the microsomal preparation of the COX-1 enzyme .
Indomethacin (Figure 2.4) is a potent inhibitor of COX in in vitro tests. Although it is
clinically effective, it has been shown to have high incidences of side effects (RANG and
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DALE, 1987). However , it is a highly suitable compound for use as a reference
standard when testing for anti-inflammatory action of plant extracts in the COX assay.
Similarly , the selective COX-2 inhibitor, nimesulide, can be used as a reference
standard in the COX-2 assay (Figure 2.4) . The arylsulfonamide NS-398 has also been
used successfully as a COX-2 standard (NOREEN , RINGBOM, PERERA, DANIELSON





Figure 2.4 The chemical structures of (A) indomethacin (FW = 357.8) and (B)
nimesulide (FW =308.3).
The presence of polyphenols, saponins , certain pigments or fatty acids in crude plant
extracts can result in false positives in enzyme assays. It is often preferable to remove
such undesirable compounds from plant extracts priorto screening , although it is usually
easier to first test the crude extracts, and then discriminate between false and true
positive results at a later stage (O'NEILL and LEWIS, 1993).
2.2 MATERIALS AND METHODS
2.2.1 Extract preparation
S. aethiopicus plants were obtained from stock plants at the University of Natal
Botanical Garden, Pietermaritzburg. A voucher specimen was deposited in the
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University of Natal Herbarium (Light 17 NU). Mature plants were harvested in January
(summer) and divided into leaves, rhizomes and roots. This material was cut into
smaller pieces, placed in brown paper bags, and dried at 50 QC for two days. Dried
material was stored in the dark at room temperature until extraction.
Dried material was finely ground using an A10 analysis mill (Janke & Kunkel, IKA®-
Labortechnik). The material (10 g) was extracted in 100 ml solvent (water, ethanol or
ethyl acetate) in an ultrasound bath (Branson 5210) for 60 min. The extracts were
vacuum filtered through Whatman No. 1 filter paper, and dried under vacuum at 35 QC.
The residues from the plant extracts were redissolved to a concentration of 10 mg rnl'
in water (for aqueous extracts) or ethanol (for ethyl acetate or ethanol extracts) . Each
extract was tested for in vitro prostaglandin synthesis inhibition in both the COX-1 and
CQX-2 assays.
2.2.2 Testing CQX-1 inhibition
2.2.2.1 Bioassay protocol
The COX-1 assay was performed as described by JAGER, HUTCHINGS and VAN
STADEN (1996). The COX-1 enzyme (10 lJl microsome suspension from sheep
seminal vesicles, 0.35 lJg protein) was activated with 50 lJlof co-factor solution (0.3 mg
rnl" L-adrenaline and 0.3 mg ml' reduced glutathione in 0.1 M Tris buffer, pH 8.2) on
ice for 15 min. The enzyme solution (60 lJl) was added to the sample solution (2.5 lJl
ethanolic or aqueous plant extract and 17.5 lJl water) and preincubated at room
temperature for 5 min. The plant extracts were tested at a concentration of 10 mg rnl',
giving a final concentration of 250 lJg ml' per test solution. Indomethacin (5 lJM) was
tested as a positive control. For each assay, a duplicate set of samples were tested.
The reaction was started by adding 20 lJl 14C-arachidonic acid (30 lJM, 16 Ci mol")
(Amersham). Samples were incubated in a water bath for 10 min at 37 QC. The
reaction was terminated by adding 10 lJl 2 N HCI.
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Prostaglandins and unmetabolized arachidonic acid were separated by column
chromatography over silica gel, after addition of 4 1-11 0.2 mg ml' unlabeled
prostaglandins (PGE2:PGF20 1:1) (Sigma) as a carrier solution. Small silica columns
were prepared by packing silica gel (silica gel 60, 0.063-0.200 mm, Merck) to a height
of 3 cm In Pastueur pipettes stoppered with glass wool. The test solution was applied
to the column with 1 ml of hexane: 1A-dioxan :glacial acetic acid (70:30:0.2) . The
arachidon ic acid was eluted first with 4 ml of the hexane:1A-dioxan :glacial acetic acid.
The prostaglandin products were then eluted with 3 ml of ethyl acetate:methanol (85:15)
and collected in scintillation vials. After mixing with 4 ml of scintillation fluid , the samples
were counted in a Beckman LS 6000LL scintillation counter. Percentage inhibition of
the test solutions was calculated using the following formula :
% Inhibition = [ 1 [
(RADIOACTIVITY Extract - RADIOACTIVITY BaCkground)]] 0
(RADIOACTIVITY Solvent Blank _ RADIOACTIVITY Background) X 1
0
Inhibition refers to reduction of PGE2 formation in comparison to an untreated sample
(2.5 1-11 ethanol in 17.5 1-11 water) .
2.2.2.2 Enzyme preparation
The COX-1 enzyme was prepared from fresh sheep seminal vesicles . The urinary
organs were obtained from freshly slaughtered rams directly from the slaughter line at
the Ladysmith Abattoir. These were kept on ice and transported to the laboratory where
the microsomal preparation was conducted.
Eight seminal vesicles (± 4 cm in diameter) were trimmed free from fat and connective
tissue, and cut into smaller pieces on a glass petri dish placed on a layer of ice. Fifty
grams of the seminal vesicles. were placed in a beaker with 150 ml 0.1 M potassium
phosphate buffer (pH 7.4) with 1 mM EDTA (ethylene diamine tetra-acetic acid disodium
salt). The beaker was kept on ice, and the mixture homogenized using an Ultra-Turrax
T25 homogenizer (Janke &Kunkel, IKA®-Labortechnik) at medium speed.
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The homogenate was centrifuged at 4000 g for 15 min (Sorvall RC-5 Centrifuge) to
remove cell debris . The supernatant was decanted and centrifuged at 17 000 g for 10
min to remove the mitochondria. The microsomes were isolated from the supernatant
by ultracentrifugation of 60 ml at 100000 g for 1 h (Beckman L-80 Ultracentrifuge). The
resulting pellet was resuspended in 0.1 M potassium phosphate buffer (pH 7.4).
The protein concentration was determined using the Bio-Rad Protein Assay Kit. The
standard procedure was slightly modified by pipetting 20 ~I of each standard or sample
solution and 1 ml of the diluted dye reagent directly into a cuvette. A standard curve
was constructed using bovine serum albumin (BSA) as a protein standard at
concentration range from 0.2 to 1.2 mg rnl' (Figure 2.5). The protein concentration of
the enzyme preparation was diluted with 0.1 M potassium phosphate buffer (pH 7.4) to
approximately 10 mg rnl" , by comparing appropriate dilutions against the standard
curve. Aliquots of 1a, 100 and 1000 ~I were pipetted into Eppendorf tubes and stored
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Figure 2.5 BSA standard curve for the determination of the protein concentration of
the microsomal preparation.
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2.2.2.3 Optimization of the bioassay
The optimum concentration and incubation time of the enzyme preparation for use in
the COX-1 assay was determined by testing various enzyme concentrations, followed
by testing a range of incubation times .
2.2.2.4 Enzyme concentration
The enzyme preparation was tested in the COX-1 assay at various dilutions ranging
from 0 to 1%. Solvent blanks (2.5 1-11 ethanol and 17.5 1-11 water) were used as the test
solutions, and the incubation time at 37 QC was 10 min. From the results obtained, a
suitable enzyme concentration for use in the COX-1 assay was determined, by choosing
a dilution giving approximately a third of the total radioactivity of the 14C-arachidonicacid
(i.e. 300-360 kBq).
2.2.2.5 Optimal incubation time
The optimal incubation time for the arachidonic acid and enzyme at 37 QC was tested
using enzyme concentrations of 0.3,0.35 and 0.4% at a range of incubation times from
oto 20 min.
2.2.2.6 Indomethacin standard curve
Indomethacin solutions, ranging between 10-7 M to 10-5 M, were assayed for activity in
the COX-1 assay. From the results obtained, a dilution curve was constructed, and the
IC50 value determined using regression analysis of the log concentrations.
2.2.3 Testing CQX-2 inhibition
2.2.3.1 Bioassay protocol
The COX-2 assay was performed as described by NOREEN, RINGBOM, PERERA,
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DANIELSON and BOHLlN (1998) , with slight modifications (ZSCHOCKE and VAN
STADEN , 2000). The COX-2 assay follows a very similar protocol as the COX-1 assay .
Purified COX-2 enzyme from sheep placental cotyledons was purchased from Cayman
Chemicals . The enzyme (1 0 ~I containing 3 units) was activated with 50 ~I co-factor
solution (0.6 mg rnl' L-adrenaline, 0.3 mg rnl' reduced glutathione and 1 IJM hematin
in 0.1 M Tris buffer, pH 8.0) on ice for 5 min. The enzyme solution (60 ~I) was added
to the sample solution (2.5 IJI ethanolic or aqueous plant extract and 17.5 ~I water) and
preincubated at room temperature for 5 min. The plant extracts were tested at a
concentration of 10 mg rnl' , giving a final concentration of 250 IJg rnl' per test solution .
Positive control measurements were carried out with indomethacin and nimesulide at
concentrations of 200 ~M . For each assay, a duplicate set of samples were tested.
The reaction was started by adding 20 ~I "Cvarachidonic acid (30 ~M, 16 Ci mol")
(Amersham). Samples were incubated in a waterbath for 10 min at 37 QC. The reaction
was terminated by adding 10 ~I 2 N HCI. Prostaglandins and unmetabolized
arachidon ic acid were separated and COX-2 inhibition was determined as described for
the COX-1 assay.
2.2.3.2 Indomethacin standard curve
Indomethacin solutions, ranging between 10-5 M to 10-3 M, were assayed for activity in
the COX-2 assay. From the results obtained, a dilution curve was constructed, and the
ICso value determ ined using regression analysis of the log concentrations.
2.3 RESULTS AND DISCUSSION
2.3.1 Enzyme preparation and bioassay optimization
The results of testing different enzyme concentrations are shown in Figure 2.6. A
concentration of 0.4% gave a value of approximately 240 kBq. This value was slightly
less than a third of the radioactivity of the 14C-arachidonic acid substrate, which is the
maximum level of conversion that is within the linear range. Testing of an enzyme
concentration of 0.5% resulted in a very steep curve, and further testing to determine
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the optimal incubation time was therefore conducted at enzyme concentrations of 0.3 ,
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Figure 2.6 Standard curve forthe determination of the optimal enzyme concentration
for the COX-1 assay.
Testing the different enzyme concentrations at varying incubation times did not result
in a curve with a clear linear relationship as expected (Figure 2.7). However, at an
enzyme dilution of 0.35% and an incubation time of 10 min the enzyme activity was
approximately steady, and the radioactivity sufficiently high (300-360 kBq) . This
concentration and incubation time was therefore chosen for use in the COX-1 assay, in
order to fulfill the requirements of a repeatable assay in which many samples can be
tested together (NOREEN, RINGBOM, PERERA, DANIELSON and BOHUN, 1998).
Results from the tests to optimize the enzyme concentration and time duration for the
COX-1 assay illustrate the sensitive nature of the assay system. Although it has been
used successfully for studying in vitro inhibition of prostaglandin synthesis, it is important
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Figure 2.7 Standard curves for the determination of the optimal incubation time and
enzyme concentration for the COX-1 assay. (Enzyme dilutions: .0.3%;
o 0.35%; • 0.4%).
2.3.2 Indomethacin standard curves
The inhibition of COX-1 and COX-2 by various concentrations of indomethacin are
shown in Figures 2.8 and 2.9. The ICso for indomethacin in the COX-1 assay was
calculated to be 0.9 IJM and in the COX-2 assay to be 5.3 IJM. Although indomethacin
is not a COX-2 specific inhibitor, it does show inhibition of COX-2 at higher

































Figure 2.9 Standard curve for the inhibition of COX-2 by indomethacin.
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2.3.3 CQX-1 inhibition by S. aethiopicus extracts
The results for the COX-1 assay are shown in Figure 2.10. Aqueous extracts showed
no noteworthy activity. Ethanol and ethyl acetate extracts of the leaves showed high
levels of COX-1 inhibition. These results confirm the findings of ZSCHOCKE, RASE,
TAYLOR, JAGER and VAN STADEN (2000) that the leaves of S. aethiopicus showed
the highest levels of COX-1 inhibition . The rhizome and root extracts showed lower
levels of activity, with the ethyl acetate extracts having slightly higher activity than the

















Figure 2.10 COX-1 inhibition of water, ethanol and ethyl acetate extracts of various
plant parts of S. aethiopicus. Extracts were tested at a final concentration
of 250 I-Ig rnl' per test solution. Values represent the mean of double
determinations. The indomethacin standard inhibited the synthesis of
prostaglandins by 71%.
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These results do provide some evidence for the rational use of this plant in traditional
medicine for anti-inflammatory purposes. However , activity was mainly observed with
organic solvent extracts, and not with aqueous extracts. Traditional healers would most
likely prepare hot aqueous extracts of the rhizomes or roots, whereas the aqueous
extracts prepared in this study were cold extractions. A hot extract would also extract
some of the volatile oils, possibly responsible for some of the anti-inflammatory action
(HUTCHINGS, 1989; VAN WYK, VAN OUDTSHOORN and GERICKE, 1997).
2.3.4 CQX-2 inhibition by S. aethiopicus extracts
Inhibition of the various extracts in the COX-2 assay are shown in Figure 2.11.
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Figure 2.11 COX-2 inhibition of water, ethanol and ethyl acetate extracts of various
plant parts of S. aethiopicus. Extracts were tested at a final concentration
of 250 I-Ig ml' per test solution. Values represent the mean of double
determinations. Indomethacin and nimesulide standards inhibited the
synthesis of prostaglandins by 54% and 33% respectively.
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As was seen with the COX-1 assay, the ethanol and ethyl acetate extracts of the leaves
showed the highest levels of activity. Similarly, the rhizome and root extracts showed
lower levels of activity with the ethyl acetate extracts having slightly higher activity than
the ethanolic extracts. The aqueous extracts showed no noteworthy activity, although
those of the rhizomes and leaves were slightly higher than the root extract.
In this investigation, the use of an in vitro enzyme assay to test for inhibition against the
COX-1 or COX-2 enzyme provided an appropriate method for determining the presence
of inhibitory activity by crude plant extracts. It also provided a means for comparing
levels of activity between different extracts. /n vitro bioassay systems are suitable for
the investigation of biological activities of extracts, fractions and isolated compounds.
They are advantageous for activity guided fractionation, where a large number of
samples require testing (KIUCHI, IWAKAMI, SHIBUYA, HANAOKA and SANKAWA,
1992).
Similar bioassays have been used successfully to isolate compounds from Zingiber
officina/e which have shown activity against COX-1 and 5-lipoxygenase (KIUCHI,
IWAKAMI, SHIBUYA, HANAOKA and SANKAWA, 1992). Although such studies have
shown in vitro activity of compounds from Z. officina/e, no significant effect of ginger
extract could be demonstrated in a randomized, placebo-controlled, cross-over study
with ibuprofen in patients with osteoarthritis (BLlDDAL, ROSETZSKY, SCHLlCHTING,
WEIDNER, ANDERSEN, IBFELT, CHRISTENSEN, JENSEN and BARSLEV, 2000).
This does not necessarily negate the possible positive effect of this popular herbal
remedy. However, it does highlight the necessity for further in vivo studies and clinical
trials of herbal extracts and isolated compounds which show promising activity.
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2.4 SUMMARY
Water, ethanol and ethyl acetate extracts were prepared from the leaves ,
rhizomes and roots of S. aethiopicus, and tested in the COX-1 and COX-2
assays.
• Aqueous extracts showed no significant prostaglandin synthesis inhibition.
Ethanol and ethyl acetate extracts of the leaves showed the highest COX-1 and
COX-2 inhibition .
• Ethanol and ethyl acetate extracts of the rhizomes and roots also showed
moderate levels of activity in the COX-1 assay.
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3 Investigation of Antibacterial Activity
3.1 INTRODUCTION
3.1.1 Antibacterial agents
The important discovery of the ability of penicillium fung i to suppress the growth of
various bacterial cultures , by Fleming in 1928, promoted great interest in the discovery
and development of chemotherapeutic agents in the twentieth century (LAURENCE and
BENNETT, 1980). Programmes for the screening of fungi , actinomycetes and bacteria
for antibiotic production were conducted following the success of penicillin for the
treatment of casualties during the Second World War. These screening programmes
led to the successful isolation of streptomycin, the tetracyclines, erythromycin and other
antibiotics (LAURENCE and BENNETT, 1980).
By definition , the term antibiotic refers to substances produced by micro-organisms that,
in high dilution, destroy or inhibit the growth of other micro-organisms (LAURENCE and
BENNETT, 1980), although in practice it has become synonymous with
antibacterial/antimicrobial agents . These are terms which are used to describe
chemotherapeutic agents used against micro-organisms, and includes compounds such
as sulphonamides, isoniazid and quinine (not true antibiotics).
The term chemotherapy refers to the drug treatment of various infections (bacteria ,
viruses , protozoa, fungi ,worms), in which the agent of infection is removed or destroyed
without injuring the host or affecting host cells. The term also includes the therapy of
cancer (LAURENCE and BENNETI, 1980) .
3.1.2 Action of antibacterial agents
Bacteria are generally classified as either Gram-positive or Gram-negative. This
classification is based on whether the organisms do or do not stain with Gram's stain.
Although based on a simple staining react ion, Gram-positive and Gram-negative
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bacteria are different in several respects. With regard to the action of antibiotics, these
differences play an important role (RANG and DALE, 1987).
The cell wall of a Gram-positive organism is a relatively simple structure which forms no
appreciable barrier to the entry of antibiot ics. It contains many layers of peptidoglycan,
between 15-50 nm thick, and can be easily separated from the plasma membrane. The
surface is highly polar and carries a negative charge (RANG and DALE, 1987; PAGE,
CURTIS, SUTTER, WALKER and HOFFMAN , 1997).
Gram-negative organisms have a more complex cell wall structure. From the plasma
membrane outwards it consists of: (1) a periplasmic space containing enzymes and
other components; (2) a 2 nm peptidoglycan layer, often linked to outward projecting
lipoprotein molecules ; (3) an outer membrane consisting of a lipid bilayer with protein
molecules and complex lipopolysaccharides on its outer surface. These
polysaccharides are different in different strains, and are the main determinants of the
antigenicity of the organism. They form the "endotoxins" which trigger various aspects
of the inflammatory reaction of a bacterial infection (RANG and DALE, 1987).
Many antibiotics are less active against Gram-negative than Gram-positive bacteria,
probably as a result of the complex outer layer which is more difficult to penetrate.
However, proteins in the outer membrane of Gram-negative bacteria form
transmembrane water-filled channels , called "porins", through which hydrophilic
antibiotics can move freely (RANG and DALE, 1987).
Antibacterial agents can be generally divided into two groups , those which act primarily
by stopping bacterial growth (bacteriostatic) and those which act by killing the bacteria
(bactericidal). However, some drugs are bacteriostatic or bactericidal according to their
concentration, and most bacteriostatic drugs can be shown to be bactericidal at high
concentration. These differences do, however, have relevance in relation to combined
therapy (LAURENCE and BENNETT, 1980).
The lowest concentration at which an antibacterial agent inhibits bacterial growth is
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usually referred to as the minimum inhibitory concentration (MIC), and the lowest
concentration which is required to kill the test bacterium is known as the minimum
bactericidal concentration (MBC) or the minimum lethal concentration (MLC). In many
cases, the MBC is 2-8 times that of the MIC (PAGE, CURTIS, SUTIER, WALKER and
HOFFMAN , 1997).
Antibacterial agents are generally classified according to their mechanism of action (site
of action). These sites of action include: (1) the cell wall; (2) the cytoplasmic membrane;
(3) the inhibition of protein synthesis; (4) nucleic acid metabolism ; and (5) intermediary
metabolism (LAURENCE and BENNETT, 1980; GILLHAM, PAPACHRISTODOULOU
and THOMAS, 1997).
Two important classes of antibiotics that inhibit bacterial cell wall synthesis are ~­
lactams and glycopeptides. ~-Lactams act by inhibiting the cross-linkage of the peptide
chains of the bacterial cell wall. They include penicillins , cephalosporins , carbapenems
and monobactams. Glycopeptides are high molecularweight drugs consisting of sugars
and amino acids (e.g. vancomycin) (PAGE, CURTIS, SUTIER, WALKER and
HOFFMAN, 1997). Isoniazid, a synthetic drug, inhibits the biosynthesis of the mycolic
acid found in the outer membrane of mycobacteria (GILLHAM,
PAPACHRISTODOULOU and THOMAS, 1997).
Polymyxins act by disrupting the cytoplasmic membrane functioning of Gram-negative
bacteria. However, due to their toxicity, they are mainly used for topical therapy of
Gram-negative infections (PAGE, CURTIS , SUTIER, WALKER and HOFFMAN, 1997).
There are several major classes of antibiotics that act mainly by inhibiting bacterial
protein synthesis. They exhibit selective toxicity by inhibiting bacterial protein synthesis
to a greater extent than the host cell protein synthesis . Antibiotics with this mode of
action include aminoglycosides (e.g. gentamicin, streptomycin), amphenicols (e.g.
chloramphenicol), lincosamides, macrolides (e.g. erythromycin), streptogramins and
tetracyclines (GILLHAM, PAPACHRISTODOULOU and THOMAS , 1997; PAGE,
CURTIS, SUTTER, WALKER and HOFFMAN , 1997).
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Other classes of antibiotics act as inhibitors of nucleic acid synthesis. They include
quinolones and nitroimidazoles which inhibit the synthesis of bacterial DNA, and
rifamycins which inhibit bacterial RNA synthesis. Drugs such as sulphonamides
interfere with the bacterial folate synthetic pathway ,thus interfering with the intermediary
metabol ism (pAGE, CURTIS, SUTTER, WALKER and HOFFMAN , 1997) .
3.1.3 Bacterial resistance to drugs
The use of antibacterial drugs in the twentieth century has dramatically changed the
course of many illnesses. However. partly because of their excellent safety profiles ,
they are among the most over-prescribed drugs. As a result , this has contributed to the
expanding problem of resistance by a variety of bacteria (PAGE, CURTIS, SUTTER,
WALKER and HOFFMAN, 1997). For example, in recent years there has been an
increase of tuberculosis in the USA due to the development of multiple-drug resistance
by Mycobacterium tuberculosis (GILLHAM, PAPACHRISTODOULOU and THOMAS,
1997).
Antibiotic resistance can be classified as either innate (intrinsic) or acquired . Innate
resistance refers to the inherent resistance of an organism due to the mechanism of the
drug. Acquired resistance, however, refers to the acquisition of a resistance gene in an
organism that is not intrinsically resistant to the drug. The major stimulus for the
development of acquired antibiotic resistance in bacteria is due to the use of
antibacterial drugs themselves. Such use exerts selective pressure on the bacteria to
develop resistance in orderto survive. However, theprobability of developing resistance
does depend on the specific drug and bacterium involved (PAGE, CURTIS , SUTTER,
WALKER and HOFFMAN, 1997).
Drug resistance can be divided into two types : (1) drug tolerant, where the organism is
able to grow in the presence of the antimicrobial agent; and (2) drug destroying, where
the organism is able to inactivate the drug (e.g. penicillinase-producing staphylococci)
(LAURENCE and BENNETT, 1980).
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There are three main biochemical mechanisms of acquired resistance: (1) reduced
bacterial permeability in the cell membrane of Gram-negative bacteria ; (2) the
production of bacterial enzymes that alter the structure of the antibiotic (e.g. ~­
lactamase); and (3) alteration in the target site , where the antibiotic normally binds (e.g.
methicillin-resistant staphylococci) (PAGE, CURTIS, SUTTER, WALKER and
HOFFMAN, 1997).
A recent study in Bristol has shown that healthy 7-year-old children may carry strains
of Staphylococcus aureus, Haemophilus spp., Branhamella catarrhalis, group A ~­
haemolytic streptococci and Escherichia coli with acquired resistance to antib iotics to
which they have not been exposed (MILLAR, WALSH, L1NTON, ZHANG, LEEMING,
BENNETT and the ALSPAC Study Team, 2001) . This study illustrates the extent to
which resistant bacteria are circulating in healthy children and highlights the potential
for increasing problems related to bacterial resistance . There is therefore a great need
to continue the search for compounds which could potentially lead to the development
of safe and effective antimicrobial agents. There is also a great need for new, more
effective and less toxic antibiotics for the treatment of opportunistic infections related to
acquired immunodeficiency syndrome (AIDS) . Patients with AIDS are particularly
susceptible to certain opportunistic infections, for which conventional antibiotic therapy
is not always suitable (CLARK and HUFFORD, 1993).
3.1.4 Testing antibacterial activity
HEWITT and VINCENT (1989) describe a microbiological assay as the "technique
whereby the potency or concentration of a chemical substance may be determined by
its effect on the growth of a microorganism". Microbiological assays are important
techniques for the detection of antimicrobial substances and for the development of
effective antimicrobial agents , and are essential for process and product control in the
pharmaceutical industry (HEWITT and VINCENT, 1989) .
Assays used for testing antibacterial activity can be generally classified into 3 groups:
(1) diffusion methods; (2) dilution methods; and (3) bioautographic assays (RIOS,
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RECIO and VILLAR, 1988). The choice of technique to be used will depend on the
extract or compound to be tested , and it is important to understand the advantages and
limitations of each method . There are many factors which can influence the results
obtained and the great variation often observed in testing crude plant extracts in
antibacterial assays. These include the assay technique , the culture medium, the strain
of bacteria used for testing , the botanical source of the plant, the age of the plant , the
state of the plant material used (fresh or dried) and the quantity of extract tested
(JANSSEN, SCHEFFER and BAERHEIM SVENDSE , 1987; THOMAS, 1989).
Furthermore, there is no standardized method for expressing the results of antibacterial
testing (RIOS, RECIO and VILLAR , 1988).
The disc-diffusion assay is one of the most common forms of testing for antibacterial
activity, and does not require homogenous dispersion of the extract. A filter paper disc ,
impregnated with the test substance or extract , is placed on an inoculated medium .
There are some variations of this method which use a hole in the agar medium , or a
cylinder for the sample reservoir. After incubation the inhibition zone around the disc,
hole, or cylinder is measured. It is also possible to keep the inoculated system at a low
temperature before incubation to allow for greater diffusion of the test substance
through the culture medium (RIOS, RECIO and VILLAR, 1988). This method is not
suitable when the sample is not soluble in water , as this would result in poor diffusion
through the agar, resulting in small inhibition zones, even if the substance is highly
active.
Dilution techniques generally require a homogeneous dispersion of the sample in water.
They are often used to determine the MIC or MLC values of an extract , essential oil or
pure substance, but can also be used for the preliminary screening of crude plant
extracts for antibacterial activity (RIOS, RECIO and VILLAR, 1988). As is the case with
the diffusion assays, there are different variations of the dilution technique. The most
common method is a liquid dilution method, although there are other methods which
incorporate agar in the mixture.
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The use of bioautography is a useful procedure for testing antibacterial activity and for
bioassay-guided fractionation of antibacterial compounds. Developed thin layer
chromatography (TLC) plates are allowed to dry before being sprayed with a mixture of
the test bacteria and liquid nutrient medium (direct bioautography) , or the plate may be
covered with an agar medium containing the test bacteria (overlay assay). The plates
are incubated in a humid atmosphere, resulting in inhibition zones where growth is
prevented by the active components . These inhibition zones are usually visualized
more clearly by the use of tetrazolium salts such as iodonitrotetrazolium chloride (INT)
or methylthiazoyl-tetrazolium chloride (MTT) (BEGUE and KLINE, 1972;
HOSTETTMANN, MARSTON and WOLFENDER, 1995; GIBBONS and GRAY, 1998).
It is often useful to include a known antibiotic in the assay as a positive control. This is
useful for establishing the sensitivity of the test organism (RIOS, RECIO and VILLAR,
1988). However, a comparison of the antibacterial activity of the samples and the
standard antibiotic cannot be drawn (JANSSEN, SCHEFFER and BAERHEIM
SVENDSE, 1987).
In this investigation two Gram-positive organisms and two Gram-negative organisms
were used as test bacteria. These were the Gram-positive Bacillus subtilis and
Staphylococcus aureus, and the Gram-negative Escherichia 'coli and Klebsiella
pneumoniae. S. aureus is an important pathogen responsible for wound infections ,
conjunctivitis, toxic food poisoning and various superficial infections (pustules , boils,
abscesses etc.) and deep infections (septicaemia, endocarditis, pyaemia). A normal
inhabitant of the human and animal intestine , E. coli, is mainly responsible for wound '
and urinary infections , and gastroenteritis. Other infections include peritonitis ,
septicaemia and neonatal meningitis. K. pneumoniae is also found in the human and
animal intestine, and is similarly responsible for urinary infections and other forms of
sepsis (RANG and DALE, 1987; SLEIGH and TIMBURY, 1998).
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3.2 MATERIALS AND METHODS
3.2.1 Extract preparation
Extracts of the leaves, rhizomes and roots of S. aethiopicuswere prepared as described
in section 2.2.1. The residues from the plant extracts were redissolved to a
concentration of 50 mg rnl' in water (for aqueous extracts) or ethanol (for ethyl acetate
or ethanol extracts) for antibacterial testing .
3.2.2 Testing antibacterial activity
3.2.2.1 The microdilution bioassay
Antibacterial activity was assessed using the microdilution bioassay, as described by
ELOFF (1998). Each extract was tested against bacterial strains obtained from the
bacterial collection of the Microbiology Department, University of Natal, Pietermaritzburg
and maintained on Mueller-Hinton (MH) nutrient agar (Biolab) at 4 QC. The bacteria
tested were Bacillus subtilis and Staphylococcus aureus (Gram-positive), and
Escherichia coli and Klebsiella pneumoniae (Gram-negative).
/
For each test bacterium, 100 1-11 of redissolved extract was serially diluted two-fold with
100 1-11 sterile distilled water in a sterile 96-well microtitre plate . A similar two-fold serial
dilution of neomycin (100 IJg rnl') was used as a positive control for each bacterium .
Extract and bacteria-free negative controls were also included.
Suspension cultures of bacteria were inoculated in Mueller-Hinton (MH) broth (Oxoid)
from stock cultures and incubated overnight at 37 QC in a waterbath on an orbital shaker.
Prior to use in the bioassay , the saturated suspension cultures were diluted 1:100 with
sterile MH broth. To each of the wells containing the test or control solutions, 100 IJI of
the bacterial cultures were added. The plates were covered and incubated overnight
at 37 QC.
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To indicate bacterial growth, 40 IJI of 0.2 mg rnl' iodonitrotetrazolium chloride (Sigma) ,
were added to each well, and the plates were incubated for a further 30 min. The wells
which displayed no change in colour represented antibacterial activity. The MIC was
taken as the lowest concentration of plant extract to elicit a bacteriostatic or bactericidal
effect against the tested bacterium (i.e. first well free from colour change).
3.3 RESULTS AND DISCUSSION
3.3.1 Antibacterial activity of S. aethiopicus extracts
Results for the screening of extracts from the different plant parts for antibacterial
activity are shown in Table 3.1. No inhibitory activity against the test bacteria was
detected with the aqueous extracts. The ethanol and ethyl acetate extracts tested
showed greater antibacterial activity against the Gram-positive bacteria than the Gram-
negative bacteria. No distinct differences were observed between the activity obtained
with the ethanol and ethyl acetate extracts of the different plant parts , or between the
activity of the different plant parts .
Table 3.1
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Minimum inhibitory concentrations (mg rnl' ) of S. aeth iopieus extracts
against test bacteria.
Bacterium"
Plant part Extract B.s. S.a. Ee. K.p .
Leaves Water > 12.5 > 12.5 > 12.5 > 12.5
Ethanol 3.13 1.56 3.13 3.13
Ethyl acetate 1.56 1.56 3.13 6.25
Rhizome Water > 12.5 > 12.5 > 12.5 > 12.5
Ethanol 1.56 1.56 3.13 6.25
Ethyl acetate 1.56 1.56 6.25 6.25
Roots Water > 12.5 > 12.5 > 12.5 > 12.5
Ethanol 1.56 0.78 6.25 6.25
Ethyl acetate 0.78 1.56 6.25 12.5
Neomycin standard (I..Ig rnl') 0.1 0.1 1.56 0.39
Abbrev iations: a 8.s. - 8. subtilis; S.a. - S. aureus ; E.c. - E. coli; K.p. - K. pneumoniae.
As discussed in section 1.3.4, the rhizome and roots contain a large proportion of
volatile oils, the major constituents of which are 4aaH-3,5a,8a~-trimethyl-4,4a,9­
tetrahydro-naphtho[2,3-b]-furan-8-one, 1,8-cineole , (E)-~-ocimene and eis-allooc imene
(VILJOEN, DEMIRCI , BASER and VAN WYK, 2002) . Many stud ies have been
conducted on the antibacterial effects of essential oils , and their components. Table 3.2
gives an indication of the antibacterial activity of some of the essential oil components
identified in S. aethiopieus root and rhizome oils (VILJOEN, DEMIRCI , BASER and VAN
WYK,2002).
Table 3.2 Some essential oil components from S. aethiopicus root and rhizome oil (and percentage composition) (VILJOEN ,
DEMIRCI, BASER and VAN WYK, 2002) and related antibacterial activity.
Compound % Roots % Rhizomes Comments Reference
bornyl acetate 0.08 - Inactive against S. aureus, E. coli and HINOU, HARVALA and HINOU, 1989 ;
P. aeruginosa; Moderately active KNOBLOCH, PAULI, IBERL,
against a variety of organisms WEIGAND and WEIS, 1989
camphor 0.03 - Very slight activity against a variety of KNOBLOCH, PAULI , IBERL,
organisms WEIGAND and WEIS, 1989
1,8-cineole 9.63 16.11 Little or no activity JANSSEN and SCHEFFER, 1985
p-cymene 0.43 0.22 Little or no activity against a variety of KNOBLOCH , PAULI, IBERL,
organisms WEIGAND and WEIS, 1989
Iimonene 1.68 1.17 Little or no activity JANSSEN and SCHEFFER, 1985
Iinalool 0.4 0.84 Active against S. aureus and E. coli; HINOU, HARVALA and HINOU, 1989;
Active against a variety of organisms KNOBLOCH, PAULI, IBERL,
WEIGAND and WEIS, 1989
myrcene 1.80 1.15 Did not show activity on its own , but ONAWUNMI, YISAK and
enhanced activity when combined with OGUNLANA, 1984
geranial or neral




Compound % Roots % Rhizomes Comments Reference
neryl acetate - 0.04 Active against S. aureus and HINOU, HARVALA and HINOU, 1989
P. aeruginosa
(E)-r3-ocimene 7.61 6.11 Slight activity KNOBLOCH, PAULI, IBERL,
WEIGAND and WEIS, 1989
a-pinene 0.84 0.72 Little or no activity; Inactive against JANSSEN and SCHEFFER, 1985;
S. aureus, E. coli and P. aeruginosa; HINOU, HARVALA and HINOU, 1989;
Slight activity against a variety .of KNOBLOCH, PAULI, IBERL,
organsims WEIGAND and WEIS, 1989
r3-pinene 1.96 1.86 Little or no activity; Active against JANSSEN and SCHEFFER, 1985;
S. aureus HINOU, HARVALA and HINOU, 1989
piperitone 0.04 0.01 Active against S. aureus; Active against HINOU, HARVALA and HINOU, 1989;
a variety of organisms KNOBLOCH, PAULI, IBERL,
WEIGAND and WEIS, 1989
sabinene 5.52 4.52 Active against S. aureus HINOU, HARVALA and HINOU, 1989
a-terpineol 1.01 1.71 Weak activity against a variety of test JANSSEN and SCHEFFER, 1985;
bacteria; Active against S. aureus and HINOU, HARVALA and HINOU, 1989
E. coli
terpinolene 0.58 0.22 Terpinolene active against S. aureus HINOU, HARVALA and HINOU, 1989
and E. coli, slight activity against P.
aeruginosa




Some studies have shown that the compounds in the greatest proportions are not
necessarily responsible for the greatest total activity , and that the less abundant
constituents can also play an important role (CIMANGA, KAMBU, TONA , APERS , DE
BRUYNE, HERMANS, TOTTE, PIETERS and VLlETINCK, 2002). Forexample, a study
of the antimicrobial activity of Eucalyptus oils showed that there was no direct
relationship between the 1,8-cineole content and the inhibition zones obtained
(DELLACASSA, MENENDEZ, MOYNA and CERDEIRAS , 1989).
In a study on the antibacterial constituents of the essential oil of Cymbopogon citratus
(lemon grass) , it was observed that myrcene did not show antibacterial activity on its
own against B. subtilis and E. coli. However, it enhanced the activities of either of the
other two main components , a-citral (geranial) and ~-citral (neral) when combined
(ONAWUNMI, YISAK and 'OGUNLANA, 1984).
It has also been observed that the chemical configuration of essential oils can have an
effect on the antibacterial activity. For example, in a study which screened 32 common
constituents of essential oils, it was seen that ~-pinene was more active than its isomer
a-pinene (HINOU, HARVALA and HINOU, 1989).
There has been much investigation into the method of determining antibacterial activity
for essential oils. In some cases, depending on the method used (diffusion ordilution) ,
different results can be obtained. A very important factor related to the antibacterial
activity of essential oils and their components is their solubility in water. Numerous
terpenoid compounds were tested against various bacteria and it was found that their
potency was related to their solubility in water. However, some substances (eg. thymol,
carvacrol and eugenol) which appeared less water soluble showed strong antibacterial
properties. In general , essential oils caused damage to biological membranes due to
their lipophilic properties, although specific functional groups are also effective
(KNOBLOCH, PAULI, IBERL, WEIGAND and WEIS, 1989).
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3.4 SUMMARY
Water, ethanol and ethyl acetate extracts were prepared from the leaves,
rhizomes and roots of S. aethiopicus, and tested in a microdilution antibacterial
assay .
No antibacterial activity was detected with the aqueous extracts.
Ethanol and ethyl acetate extracts showed greater activity against Gram-positive
bacteria than Gram-negative bacteria .
No distinct differences were observed between the ethanol and ethyl acetate
extracts, or between the extracts from the different plant parts.
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4 Isolation of an Antibacterial Compound
4.1 INTRODUCTION
4.1.1 Bioassay-guided fractionation
The isolation of biologically active natural compounds is often limited because they may
be present in very minute quantities. Furthermore, such substances may be thermally
or hydrolytically unstable or have unfavourable solubility properties (KINGHORN, 1992).
The isolation of an active constituent from a crude plant extract may seem somewhat
daunting in light of the fact that a plant may contain hundreds or even thousands of
compounds with a variety of different biological properties (HOSTETTMANN, 1986) .
However, despite the difficulties which may be encountered, there are numerous
separation techniques which can be employed to obtain pure compounds.
In the process of the separation of complex mixtures, the aim is to have maximum yield
with a minimum of effort in order to reduce the time and cost involved. Various types
of solid phase chromatography (thin layer chromatography, column chromatography,
low-, medium and high pressure chromatography) and liquid-liquid chromatography are
among some of the systems which are used in compound isolation. Each method has
advantages and limitations, and usually several separation steps involving different
techniques, when used in combination, make the isolation of pure compounds possible
(HOSTETTMANN, 1986; HOSTETTMANN, MARSTON and WOLFENDER, 1995).
Bioassay-guided fractionation (also known as "bioassay-directed" or "activity-directed"
fractionation) is a useful technique for the isolation of unknown substances which are,
biologically active. Extracts which exhibit a particular biological activity of interest are
purified chromatographically. Periodic evaluation with one or more bioassay systems,
results in the eventual isolation of one or more biologically active constituents
(KINGHORN, 1992).
Appropriate bioassays for the initial screening of biological activity and for monitoring
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the progress of the separation procedure are crucial to the isolation of compounds with
biological activity. In order to cope with the number of extracts or fractions from various
fractionation steps , the bioassays should ideally be simple, rapid , reproducible and
relatively inexpensive. If the active constituents are only present at low concentrations
in the crude'extracts, or the fractions , it is important that the biological test systems be
sensitive enough for the detection of active principles. Furthermore, it is important to
reduce the possibilities of false positive or false negative results (McCHESNEY, 1993;
HOSTETTMANN, MARSTON and WOLFENDER, 1995; HOSTETTMANN,
WOLFENDER, RODRIGUEZ and MARSTON, 1996).
Bioautography, as discussed in section 3.1.4 , is a useful method for the bioassay-
guided fractionation of compounds with antimicrobial activity. Both fungi and bacteria
may be investigated using these methods. However, some compounds show poor
migration through the agar overlay and may not be detected (GIBBONS and GRAY,
1998) . In such cases, it is often better to use a liquid broth medium.
According to COUZINIER and MAMATAS (1986), there are four possible outcomes from
the attempted determination of the active principle from active fractions: (1) no activity
is confirmed; (2) one or more type of activity is observed, but cannot be linked to any
particular active principle as a result of synergistic effects; (3) activity is observed, and
is attributed to an already known substance; and (4) a new chemical is.discovered,
potentially leading to the development of a new drug, or a new structural concept which
chemists can try to optimize .
4.1.2 Preparative thin layer chromatography
Thin layer chromatography (TLC) is a versatile technique which can be used for the
qualitative separation of simple mixtures. It can also be used as a powerful separation
tool for the quantitative analysis of complex mixtures (JORK, FUNK, FISCHER and
WIMMER, 1990). Although a number of other techniques exist which can be used for
compound isolation (eg. HPLC and countercurrent chromatography), many natural
products are still isolated by conventional preparative TLC (PTLC). It is still a useful
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isolation method in many cases due to its simplicity, relatively low cost and speed.
PTLC is nearly always used as a final purification step of mixtures which have been
partially purified using other chromatographic methods, such as column
chromatography, flash chromatography or vacuum liquid chromatography (VLC). Of
course, the isolation of some compounds using PTLC is not always the most suitable
method, and there is poor detection and control of elution compared to HPLC
(GIBBONS and GRAY, 1998).
There are a variety of factors which are important for the separation and subsequent
isolation of compounds using PTLC. The choice of a suitable separation system
(sorbent and solvent system), form of development (isocratic, multiple or step-gradient)
and the use of suitable detection reagents need to be considered (GIBBONS and
GRAY, 1998). An example of a useful universal reagent for natural products, that
makes colour differentiation possible, is anisaldehyde-sulfuric acid. It can be used for
the detection of antioxidants , steroids, prostaglandins, carbohydrates, phenols,
glycosides, sapogenins, essential oil components or terpenes, antibiotics and
mycotoxins (JORK, FUNK, FISCHER and WIMMER, 1990). It must be remembered ,
however, that the use of spray reagents is chemically destructive and cannot be used
directly for identifying compounds for isolation purposes.
4.1.3 Nuclear magnetic resonance spectroscopy
Following the isolation of constituents with biological activity, it is necessary to identify
the individual compounds and determine the structure of these compounds. Nuclear
magnetic resonance (NMR) spectroscopy allows for the unambiguous structural
identification of extremely complex plant constituents with just a few milligrams of
material (DEROME, 1989; PHILLlPSON, 1995). A further advantage of NMR
spectroscopy is due to the non-destructive nature of the technique which allows for the
recovery of the substance for further biological or chemical testing (AQUINO, DE
SIMONE, DE TOMMASI, PIACENTE and PIZZA, 1995).
NMR spectroscopy essentially measures the magnetic moments of its hydrogen atoms
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CH NMR) and the small magnetic moments generated by 13C atoms . Differently
substituted carbon atoms give shifts within specific ranges and provide information on
the nature of the carbon skeleton of the molecule , whereas the information from proton
NMR provide a record of the number of hydrogen atoms attached to different groups
(HARBORNE, 1984).
Strategies for structure elucidation based on two-dimensional (2-D) NMR correlations
were developed in the mid 1980's. A typical strategy using 2-D NMR data, is to link the
1H_13C resonances by a heteronuclear COSY experiment and to establish the 1H_1H
correlations by a homonuclear COSY experiment. From these correlations it is possible
to infer C-C connectivities and establish part structures . Long range connectivities can
be established using heteronuclear multiple bond correlations (HMBC). The derivation
of a planar structure is possible with these correlations. The 2-D nuclear Overhauser
exchange spectroscopy (NOESY) orthe measurement of proton coupling constants can
then be used to ascertain the relative stereochemistry of the structure (DEROME, 1989;
HANSON, 2001) .
4.1.4 Mass spectroscopy
Mass spectroscopy (MS) yields a complex fragmentation pattern, according to mass,
from the degradation of trace amounts of an organic compound. The sample is
bombarded with high-energy electrons which causes fragmentation of the chemical
bonds resulting in positively charged ions. Acceleration of these ions into a magnetic
field causes dispersion of the ions, and allows for the measurement of the size and
relative abundance of these ions (FOX and WHITESELL, 1997). In many cases, some
of the parent compound will survive the process and is recorded as a molecular ion
peak. The technique of MS requires small amounts of material and can provide an
accurate molecular weight. Furthermore , the fragmentation pattern is often
characteristic of a particular compound, and can be used for identification purposes
(HARBORNE, 1984).
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4.2 MATERIALS AND METHODS
4.2.1 Preliminary serial extraction of S. aethiopicus rhizome material
A serial extraction was performed on S. aethiopicus rhizome material using a Soxhlet
apparatus. Rhizomes were harvested from stock plants at the University of Natal
Botanical Garden, Pietermaritzburg. Mature plants were harvested in July (following
senescence) and the rhizomes cut into smaller pieces and dried at 50°C for two days.
The dried ground rhizome material (4 g) was placed in a Whatman cellulose extraction
thimble and covered with glass wool. The extraction solvent (150 ml) was heated to
boiling and maintained for 4 h. This was allowed to cool and drain, before being filtered
through Whatman No. 1 filter paper and dried under vacuum at 35°C. This procedure
was repeated for successive solvent extractions using the same rhizome material and
thimble. The solvents used were hexane, followed by ethyl acetate and then ethanol.
A Soxhlet extraction using only ethyl acetate or ethanol was performed on 4 g of ground
rhizome material.
The extracts were analysed using TLC separation, using a solvent system of
hexane:ethyl acetate (2:1). The extracts (0.25 mg) were loaded on the TLC plate (silica
gel 60 F254 , 0.25 mm, 10 cm x 10 cm, Merck) in 1 cm bands. The TLC plates were
developed over 7.5 cm. The solvent front was marked and the plates were allowed to
dry before visualisation under UV254 and UV366 . The plates were stained with
anisaldehyde-sulphuric acid reagent (AS) (0.5 ml anisaldehyde, 10 ml sulphuric acid,
85 ml ethanol and 5 ml concentrated sulphuric acid, mixed in this order). The stain was
poured over the plates and heated for 5-10 min at 110 QC.
The extracts were redissolved in ethanol and tested in the CQX-1 assay, as described
in section 2.2.2.1, at a concentration of 10 mg ml' (giving a final concentration of 250
~g ml' pertest solution). The extracts were also tested in the microdilution antibacterial
assay, as described in 3.2.2.1, against B. subtilis (ATCC 6051), S. aureus (ATCC
12600), E. coli (ATCC 11775), K. pneumoniae (ATCC 13883).
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4.2.2 Bulk extraction of S. aethiopicus rhizome material
A bulk extract of rhizome material was prepared using 6 Soxhlet extractors. In each
case dried ground rhizome material (15 g) was placed into a Whatman cellulose
extraction thimble and covered with glass wool. Ethyl acetate was used as the
extraction solvent (150 ml/apparatus). The ethyl acetate was heated to boiling and the
extraction was carried out for 4 h. The extract was allowed to cool and drain, before
being filtered through Whatman No. 1 filter paper and dried under vacuum at 35°C.
4.2.3 Bioassay-guided fractionation
The isolation of a compound which exhibited antibacterial activity in a bioautographic
assay, using S. aureus as a test organism, was conducted according to the outline
shown in Figure 4.1.














NMR and mass spectroscopy of isolated compund
Figure 4.1 Summary of steps used in the isolation of an antibacterial compound
using bioassay-guided fractionation.
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4.2.3.1 Vacuum liquid chromatography
Dry silica gel 60 (150 g) (0.040-0 .063 mm, Merck) was placed in a large vacuum liquid
chromatography (VLC) column (5 x 27 cm). The extract (::::4 g) was adsorbed onto a
small amount of the silica gel and allowed to dry before being placed as a top layer on
the silica gel in the column. A hexane :ethyl acetate gradient (hexane proportions:
100%; 85%; 80%; 75%; 70%; 65%; 60%; 50%; 40%; 30%; 20%; 10%; 0%) was used
and the solvent mixtures (400 ml) were eluted on the column under vacuum. The
fractions were collected and dried under vacuum at 35 'c.
4.2.3.2 Evaluation of VLC fractions
To evaluate the chromatographic separation of the vacuum liquid chromatographic
fractions (A-M) , and to ascertain the presence of compounds showing antibacterial
activity, TLC separation and a bioautographic assay were performed. Fractions A-M
(0.125 mg) were spotted onto 2 large TLC plates (silica gel 60 F254 , 0.25 mm, 20 cm x
20 cm, Merck). The plates were developed simultaneously in hexane:ethyl acetate
(2:1), and developed over 17.5 cm. The solvent front was marked and the plates were
allowed to dry before visualisation under UV254 and UV366 .
For the bioautographic assay, S. aureus (ATCC 12600) was used as a test organism
(MARTINI and ELOFF, 1998). An overnight culture was prepared in MH broth medium
(2 x 20 ml). The cultures were centrifuged at 3000 g for 10 min and the supernatant
medium discarded. The pellets of bacterial cells were combined and resuspended in
10 ml of fresh MH broth. This broth culture was then sprayed onto one TLC plate and
incubated overnight at 37 'c in 100% humidity. After incubation, the plate was allowed
to dry slightly before spraying with a 2 mg ml' solution of iodonitrotetrazolium chloride
(INT) (Fluka). The plate was then re-incubated for a further 30 - 60 min to allow for
colour development. Zones of inhibition appeared as white spots against a pink
coloured background (BEGUE and KLINE, 1972). The reference plate was stained with
AS reagent and heated for 5-10 min at 110 'c.
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The VLC fractions were also tested in the COX-1 assay as described in section 2.2.2.1,
at a concentration of 10 mg rnl' (giving a final concentration of 250 IJg rnl' per test
solution).
4.2.3.3 Preparative TLC
From the results obtained with the bioautographic assay of the VLC fractions, it was
decided to use fraction C for further purification and compound isolation using
preparative TLC.
Approximately 25 mg of VLC fraction C was applied to a large TLC plate (silica gel 60
F254 , 0.25 mm, 20 cm x 20 cm, Merck) in a long band. Five plates were developed
simultaneously in toluene:ethyl acetate (93:7), which gave a better separation than the
previous solvent system used. The solvent front was marked and the plates were
allowed to dry before visualisation under UV254 and UV366. The 1.2 cm wide band at R,
0.54, which showed up as a dark bank under UV254 , was scraped off each plate. Two
small strips were cut from one plate for bioautographic verification and for staining with
AS reagent. The combined silica gel scrapings were eluted 3 times with 20 ml ethyl
acetate in an ultrasound bath (Branson 5210) for 30 min. The solvent was filtered
through a 0.22 IJm Millipore filter and dried under vacuum at 35°C.
4.2.4 NMR and mass spectroscopy
NMR spectra CH, 13C, COSY, HMBC, HMQC and NOESY) of the isolated compound
were recorded in CDCI3using a Varian Inova 500 MHz NMR spectrometer at the School
of Chemical and Physical Sciences, University of Natal, Pietermaritzburg. Analysis of
the NMR spectra was performed with the help of Professor D.A. Mulholland of the
School of Pure and Applied Chemistry, University of Natal, Durban.
MS were run on a Hewlett-Packard gas chromatographic mass spectrometer (HP
5988A), at the School of Chemical and Physical Sciences, University of Natal,
Pietermaritzburg.
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4.2.5 MIC determination .
The MIC of the isolated compound was determined using the microdilution bioassay
described in section 3.2.2.1 . The compound was dissolved in ethanol at a concentration
of 12.5 mg ml' (giving a starting concentration of 3.13 mg ml') and tested against B.
subtilis (ATCC 6051), S. aureus (ATCC 12600), E. coli (ATCC 11775), K. pneumoniae
(ATCC 13883). Due to a limited amount of pure compound, only two replicates were
performed.
4.3 RESULTS AND DISCUSSION
4.3.1 Serial extraction of S. aethiopicus rhizome material
The residue yields forthe serial extraction of 4 g of S. aethiopicus rhizome material, and
the ethyl acetate and ethanol extracts are given in Table 4.1 . The TLC separation of the
extracts developed in hexane:ethyl acetate (2:1) can be seen in Figure 4.2.
Table 4.1 Residue yields for serial extraction of S. aethiopicus rhizome material
using Soxhlet extraction.
Extract Extraction Solvent Residue (g)
A Hexane 0.234
B Ethyl acetate (only) 0.280
C Ethanol (only) 0.387
0 A ... Ethyl acetate 0.049
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Figure 4.2 Chromatogram of Soxhlet extracts of S. aethiopicus rhizome material,
developed in hexane:ethyl acetate 2:1 and stained with AS reagent.
(A) Hexane; (8) EtOAc; (C) EtOH; (D) A ... EtOAc; (E) 0 ... EtOH.
From the TLC separation it can be seen that the hexane, ethyl acetate and ethanol
extracts (A-C) appeared to be quite similar. There were a number of compounds which
stained bright pink with AS reagent at Rf 0.38, 0.67, 0.76 and 0.86. For the serial
extracts (D,E), an initial extraction in hexane removed a large proportion of the
extractable compounds resulting in lower amounts of residue and fewer visible bands
on the TLC plate.
The inhibition of prostaglandin synthesis in the COX-1 assay by the Soxhlet extracts
is shown in Figure 4.3, and the antibacterial activity is given in Table 4.2. The hexane
and ethyl acetate extracts gave slightly higher activity than the ethanol extract, and the
ethyl acetate extract following a hexane extraction also showed good activity. However,
the final extract (E) showed very little COX-1 inhibition. No noteworthy differences were
observed between the different extracts in the microdilution assay, with the exception
of the final extract (E) which showed slightly lower activity against the Gram-positive
bacteria than the other extracts (indicated by a higher MIC value). In general, the
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extracts were more active against the Gram-positive bacteria (B. subtilis and S. aureus)
than the Gram-negative organisms.
Extracts prepared using a Soxhlet apparatus are subjected to high temperatures in the
solvent compartment of the apparatus. As the extracts exhibited activity in the COX-1
bioassay, and the microdilution antibacterial assay, it appeared that the heat did not
have an deleterious effect on the compounds responsible for the activity. These results
from the small-scale Soxhlet extractions showed that it would be feasible to conduct a
bulk extraction of the rhizome material of S. aethiopicus for bioassay-guided















Figure 4.3 COX-1 inhibition of Soxhlet extracts of S. aethiopicus rhizome material.
Extracts were tested at a final concentration of 250 IJg rnl' per test
solution. Values represent the mean of double determinations. The
indomethacin standard inhibited the synthesis of prostaglandins by 73%.
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Table 4.2 Minimum inhibitory concentrations (mg m101) of Soxhlet extracts of S.
aethiopicus rhizome material against test bacteria (ATCC cultures).
Bacterium"
Extract B.s. S.a. E.c. K.p.
(A) Hexane 0.39 0.39 6.25 6.25
(B) Ethyl acetate (only) 0.39 0.39 6.25 6.25
(C) Ethanol (only) 0.39 0.39 6.25 3.13
(0) A -+ Ethyl acetate 0.39 0.39 3.13 3.13
(E) 0 -+ Ethanol 6.25 6.25 3.13 3.13
Neomycin standard (j..Jg ml') 0.025 0.78 0.78 0.78
Abbreviations: a 8.s. - 8 . subtifis; S.a. - S. aureus ; E.c. - E. coli; K.p. - K. pneumoniae.
4.3.2 Bulk extraction of S. aethiopicus rhizome material
The ethyl acetate extract obtained from the bulk extraction of the rhizome material
resulted in a clear bright yellow extract. It dried down to a thin orange oil (6.309 g) with
a strong "ginger-like" aroma. This residue represents 7.01% of the dry material and
1.85% of the fresh material used. In comparison, hydrodistilling fresh roots and
rhizomes for three hours yielded a yellow oil which was 0.1 % of the wet weight
(VILJOEN, OEMIRICI, BASER and VAN WYK, 2002).
4.3.3 Bioassay-guided fractionation
4.3.3.1 Vacuum liquid chromatography
The residue yields for the fractions obtained from the VLC of :::: 4 g of the ethyl acetate
bulk extract of S. aethiopicus rhizomes are given in Table 4.3. Fraction C yielded the
highest amount (1.236 g) and fraction M the lowest amount (0.018 g).
Table 4.3
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Residue yields for the fractions obtained from the VLC of the ethyl acetate
extract of 5. aethiopicus rhizome material.
Fraction Hexane:EtOAc Residue (g) Fraction Hexane:EtOAc Residue (g)
A 100:0 0.388 H 50:50 0.113
B 85:15 1.008 40 :60 0.357
C 80:20 1.236 J 30:70 0.125
D 75:25 0.087 K 20:80 0.167
E 70:30 0.069 L 10:90 0.037
F 65:35 0.379 M 0:100 0.018
G 60:40 0.066
4.3.3.2 Evaluation of VLC fractions
The TLC separation of the VLC fractions and the corresponding bioautographic assay
(5. aureus) can be seen in Figure 4.4. The chromatogram which was stained with AS
reagent gave a clear indication that the VLC was a successful method of initial
separation of the bulk extract. Extracts A to G showed little overlap of similar
compounds, although fractions H to M were quite similar in nature (this is also evident
in the bioautography) . The AS stained plate also served as a reference plate for the
bioautographic assay.
The bioautography showed a number of clear zones against a pink background.
Inhibition zones were visible in fractions: Band Cat R,0.75; C and D at R,0.6; D at
Rf 0.56; E at the origin; and H to M along the origin . There was also a large clear zone
in fraction G which did not correspond with any compound visible on the reference plate
(or visible with UV). The bioautography was repeated and similar results were obtained,
thus eliminating the possibility of an error in the technique with the first attempt. Fraction
C was chosen for further purification using preparative TLC.
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These clear zones give an indication of antibacterial activity by compounds present in
these areas. However, lipophilic compounds may also result in clear zones because
the innoculated nutrient broth may not sufficiently wet the area due to the hydrophobic
nature of the compounds (JORK, FUNK, FISCHER and WIMMER, 1990).
ABCDEFGHIJKLM ABCD E FGH I J KLM
Figure 4.4 Chromatogram of vacuum liquid chromatography fractions A-M,
developed in hexane:ethyl acetate 2:1: (A) stained with AS reagent, and
(8) the corresponding bioautographic assay using S. aureus as a test
organism. Arrows indicate corresponding zones.
The results for the COX-1 assay of the VLC fractions, tested at 10 mg rnl', are shown
in Figure 4.5. The highest COX-1 inhibition was obtained with fractions A (86%), E
(76%), G (87%) and H (82%). COX-1 inhibition with the remaining fractions ranged
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Figure 4.5 CQX-1 inhibition of VLC fractions . Extracts were tested at a final
concentration of 250 I-Ig rnl' per test solution. Values represent the mean
of double determinations. The indomethacin standard inhibited the
synthesis of prostaglandins by 73%.
4.3.3.3 Preparative TLC
Fraction C was chosen for further separation due to the high yield of this fraction and
the apparent separation of the compound showing antibacterial activity from other
compounds in the fraction with TLC. Using PTLC, 24.8 mg of the compound marked
with arrows in Figure 4.4 and visible as a dark band under UV254 at Rf 0.54 (toluene:ethyl
acetate 93:7), was isolation. Two narrow strips from one of the TLC plates were used
for staining with AS reagent , and for a bioautographic assay. The band stained bright
pink with AS reagent, and corresponded with a clear zone in the bioautographic assay
(S. aureus).
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It is important to verify the presence of a compound with staining reagents and/or
bioautographic assays, because the resolution of a compound separated on an
analytical plate can change significantly when the amount of mixture is increased for
PTLC. GIBBONS and GRAY (1998) suggested that this is possibly attributable to
sorbent particle size.
4.3.4 NMR and mass spectroscopy
Furanoeremophil-2-en-1-one (C1sH180Z' FW =230.13) was isolated as an amorphous
compound. The presence of 15 carbon resonances in the 13C NMR spectrum indicated
that this compound was a sesquiterpenoid . At the time of the investigation , this
compound had not been reported previously in the chemical literature and a full
assignment of the NMR spectra was undertaken to determine the structure (Table 4.4).
The NMR spectra appear in Appendix 2.
The relative stereochemistry could be assigned by means of the NOESY spectrum and
is given in the structure shown in Figure 4.6. The COSY spectra show the H-H coupling
and the HMBC spectra show 3 -bond coupling (and occasionally 2 and 4 bond coupling)
and are reported here as C~H correlations. The NOESY spectra show correlations
through space and show hydrogen atoms close to one another, allowing for the
determination of the stereochemistry.
Figure 4.6 Structure of the furanosesquiterpenoid furanoeremophil-2-en-1-one
isolated from the rhizome of S. aethiopicus.
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Table 4.4 lH , 13C , COSY , HMBC and NOESY NMR data for the compound isolated
from S. aethiopicus (CDCI3, 500 MHz).
Carbon 1H 13C COSY HMBC C~H NOESY
1 204.14 3, 5, 14
2 5.94 d 10.1 126.56 2,4 15w 3
3 6.77 dd 10.1 ,2.1 154.31 3 4, 15 2,4,15
4 2.42 m 34.2 5, 15 2,3,5, 6a, 15 3, 6~, 14,
15
5 1.84 td 5.2, 10.7 44.91 4,2H-6 2, 9a, 9~, 14, 15 6~,9~ , 15
6 ~ 2.15 m 22.51 5,6a 5 4, 6a, 14
a 2.64 m 5,6~ *
7 114.62 6~ , se , 9a, 9~,
13
8 149.24 - 6~, se, se. 9~ ,
13w
9 a 2.76 dd 1.3, 16.9 31.93 9~ 14, 5 *
~ 2.67 d 16.9 9a *
10 44.92 3, 6~, s«
11 119.04 - 6a,13
12 7.05 137.48 13 13 13w
13 1.93d1 .2 8.08 12 6?, 12, 15
14 1.05 s 16.56 5, 9a , 9~ 6~, 4, 9~
15 1.23 d 7.2 18.08 4 3,4,5 4,5,6a
* Resonances superimposed - can't distinguish correlations.
The results for the GC-MS 70eV, m/z (% reI. int.) , are: 230 (100), 215 (96) , 197 (18) ,
187 (75) . The structure of the isolated compound (from NMR) and the GC-MS results
correlated with the recently reported data for the compound 4aaH-3,5a ,8a~-trimethyl-
4,4a ,9-tetrahydro-naphth6[2,3-b]-furan-8-one which was isolated from the essential oils
of S. aethiopicus (HOLZAPFEL, MARAIS, WESSELS and VAN WYK, 2002).
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4.3.5 MIC determination
The results for the MIC determination of the isolated compound are shown in Table 4.5.
Only a very minimal bacteriostatic effect was observed in the microdilution antibacterial
assay (0.1 to 3.13 mg rnl') . There was slightly higher activity against the Gram -positive
bacteria than the Gram-negative bacteria. However, the levels of activity of the isolated
compound seen in this assay did not differ from activity obtained with the crude extracts
(section 3.3.1, Table 3.1).
The crude extracts were tested against bacterial cultures obtained from the Microbiology
Department, University of Natal, Pietermaritzburg (section 3.2.2.1), whereas the isolated
compound was tested against ATCC culture strains. A comparison of the MIC values
of the neomycin control (section 3.3.1, Table 3.1; Table 4.5) gives an indication that the
ATCC strains are more resistant than the cultures obtained from the Microbiology
Department. The MIC values of the neomycin against the ATTC strain of S. aureus was
62-fold higher, and the ATCC strain of the B. subtilis was 8-fold higher than obtained
against the Microbiology Department cultures. However, the bioautographic assay was
performed using the more resistant ATCC strain of S. aureus and did present zones of
inhibition and apparent compound "activity".
Table 4.5 Concentrations (mg rnl") at which the isolated compound from S.
aethiopicus rhizome showed a bacteriostatic effect against test bacteria
(double determination).
Bacterium"
B.s. S.a. E.c. K.p.
Sesquiterpenoid 0.78 0.1 3.13 3.13
Neomycin standard (I.1g ml') 0.78 6.25 1.56 1.56
Abbreviations: a 8.s. ·8. subti/is; S.a. - S. aureus; E.c. - E. coli; K.p. - K. pneumoniae.
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Following the microdilution assay , the mixture from one of the wells of the 96-microtitre
plate was removed and dried under nitrogen. This residue was spotted on a TLC plate
and developed in hexane :ethyl acetate (2:1) to verify the presence of the compound, in
comparison to an untested sample. From this simple procedure it was ascertained that
the compound was present, and had not degraded (a possible explanation for the low
activity in the assay) . As mentioned earlier, it is possible that the lipophil ic nature of the









A preliminary serial extraction of S. aethiopicus rhizome material was conducted
using a Soxhlet apparatus.
Extracts were tested in the CQX-1 assay and microdilution antibacterial assay.
Hexane and ethyl acetate extracts gave slightly higher CQX-1 inhibition than the
ethanol extract.
No distinct differences were observed in the microdilution assay.
A bulk ethyl acetate extract of S. aethiopicus rhizome material was prepared.
VLC of z4 g of extract was performed, yielding 13 fractions.
The VLC extracts were evaluated using TLC and a bioautographic assay, and
tested in the CQX-1 assay.
The bioautography, using S. aureus as a test organism, revealed a number of
compounds present which exhibited antibacterial activity .
Fraction C was purified further using PTLC, and 24.8 mg of a pure compound
from Rf 0.54 (toluene:ethyl acetate 93:7) was isolated.
NMR spectra and GC-MS spectra for the isolated compound were recorded.
The compound was identified as the sesquiterpenoid furanoeremophil-2-en-1-
one, which is structurally identical to the recently reported compound 4aaH-
3,5a,8a~-trimethyl-4,4a,9-tetrahydro-naphtho[2,3-b]-furan-8-one.
The compound showed only a very minimal bacteriostatic effect In the
microdilution assay.
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5 Effect of Senescence and Post-harvest Handling on
Anti-inflammatory and Antibacterial Activity
5.1 INTRODUCTION
An important aspect of the bioactivity of med icinal plants stems from the fact that plants
do not consistently produce the same chemicals , in the same quantities . As a result,
the potency of medicinal plants is affected by a number of factors , such as the
biochemical factors within individual species and external factors such as climate,
geographical location, season and other ecological and growth conditions (PRANCE,
1994) . Variation of the activity can also occur due to treatment after collection (storage
and preparation) (COLEGATE and MOLYNEUX, 1993; HOUGHTON and RAMAN,
1998) .
In a study of the essential oils of Tagetes minuta harvested at different locations at
precise growth stages , CHALCHAT, GARRY and MUHAYIMANA (1995) showed that
the oil yield varied during plant growth, being higher in younger plants (before flowering).
Although the study showed no differences in oil composition between samples obtained
from cultivated or wild plants from different locations in France, the French oils did show
higher levels of (Z)-~-ocimene and tagetenone compared -to the samples from Rwanda .
Seasonal variation in the schizontocidal effect of leaf extracts of Morinda lucida , a plant
commonly used against fever in Nigeria, was shown by MAKINDE, AWE and SALAKO
(1994). Their study illustrated that samples collected in March showed highest activity
on an early infection and on established infections of Plasmodium berghei berghei in
mice , and least activity from samples collected in December.
The seasonal variation in growth and chemical constituents of real ginger, Zingiber
officinale, cultivated in Egypt was investigated by EL-GENGAIHI and WAHBA (1995) .
The volatile oil constituents of the shoots showed some variation over the course of an
annual growth cycle.
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In a study of the hypericin and pseudohypericin content of Hypericum perforatum (St.
John's Wort) over two seasons , SOUTHWELL and BOURKE (2001) demonstrated the
seasonal variation in the narrow and broad leaf biotypes. Their investigation showed
that the total-hypericin concentration in the soft tops of the plants of both biotypes were
lowest during the winter months and reached maximum values in summer.
Furthermore, the narrow leaf biotype consistently showed higher levels of total-
hypericins than the broadleaf biotype.
In a study on the essent ial oils from fresh and dried rhizomes of Alpinia galanga
(Zingiberaceae), JANSSEN and SCHEFFER (1985) showed that the oil from dried
material generally had greater activity than the fresh oil against various micro-organisms
(fungi, yeast and bacteria).
The examples discussed above indicate that seasonal changes can indeed have an
effect on the biological activity of certain plants. It is therefore an important
consideration to examine any possible seasonal effects which may influence the
biological activity of a plant under investigation.
s. aethiopicus plants are summer growing and become dormant in winter (GORDON-
GRAY, CUNNINGHAM and NICHOLS, 1989). In the spring, new rhizomes develop from
the mother rhizome, and new plants develop . This part of the investigation on the
medicinal properties of S. aethiopicus was undertaken to determine if any differences
in anti-inflammatory and antibacterial activity could be detected between plants
harvested in summer, and once the plants had fully senesced . Extracts prepared from
fresh material and from dried material were also tested to investigate the effect of the
state of the material on biological activity .
5.2 MATERIALS AND METHODS
5.2.1 Extract preparation
Plants of S. aethiopicus were harvested at the end of summer, prior to senescence
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(green leaves), and after the plants had fully senesced (Figure 5.1). For each set of
extracts, plants were divided into leaves, rhizomes and roots, differentiating between
a- and ~-rhizomes and roots. The mature rhizomes, and associated roots, from the
previous year's growth were classified as a-rhizomes and roots (i.e. mother rhizome
and roots), and the younger rhizomes, and roots, which develop from the a-rhizome at
the start of the growing season were classified as ~-rhizomes and roots (i.e. daughter
rhizome and roots) (Figure 5.1).
Figure 5.1 S. aethiopicus plants harvested (A) before senescence, and (B) after
senescence, showing a- and ~-rhizomes .
Portions (10 g) of the freshly harvested material was extracted in 100 ml ethanol using
a Waring blender, and then placed in an ultrasound bath (Branson 5210) for 60 min.
The remaining material was dried at 50 0 C for 2 days prior to extraction in the same
manner. The extracts were vacuum filtered through Whatman No. 1 filter paper, and
dried under vacuum at 35 QC. Two sets of extracts were prepared for plants harvested
before and after senescence.
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5.2.2 TLC fingerprinting
TLC fingerprints of the different extracts were prepared by loading 0.5 mg of each
extract in a 1 cm band onto 10 x 10 cm plastic-backed TLC plates (silica gel 60 F254'
0.25 mm, Merck). The plates were. developed in hexane:ethyl acetate (2:1), and
developed over 7.5 cm. The plates were allowed to dry, and follow ing examination
under UV254nm and UV366nm' were stained with AS reagent and heated for 5 - 10 min at
110°C.
5.2.3 Testing COX-1 inhibition
The extracts were redissolved in ethanol and tested in the CQX-1 assay, as described
in section 2.2.2 .1, at a concentration of 10 mg ml' (giving a final concentration of 250
I-Ig rnl' per test solution) .
5.2.4 Testing antibacterial activity
Antibacterial activity was assessed using the microdilution bioassay as described in
section 3.2.2.1. The residues from the plant extracts were redissolved in ethanol at a
concentration of 50 mg ml' . Each extract was tested against bacterial strains obtained
from the bacterial collection of the Microbiology Department, University of Natal,
Pietermaritzburg and maintained on Mueller-Hinton nutrient agar (Biolab) at 4°C. The
bacteria used were B. subtilis , S. aureus (Gram-positive) and E. coli , K. pneumoniae
(Gram-negative) .
5.3 RESULTS AND DISCUSSION
5.3.1 TLC fingerprinting
The TLC fingerprints for extracts prepared from the different plant parts before and after
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Figure 5.2 TLC fingerprints of green and senesced leaves of S. aethiopicus. L(g) =
green leaves; L(s) =senesced leaves; F =fresh material; 0 =dried
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Figure 5.3 TLC fingerprints of rhizomes of S. aethiopicus before and after
senescence. Rha = a-rhizome; RhP = p-rhizome; (g) = rhizomes before
senescence; (s) = rhizomes after senescence; F = fresh material; 0 =







RtP(g) RtP(g) RtP(s) RtP(s) Rta(g) Rta(g) Rta(s) Rta(s)
F 0 F 0 F 0 F 0
Figure 5.4 TLC fingerprints of roots of S. aethiopicus before and after senescence.
Rta =a-roots; Rtp =p-roots; (g) =roots before senescence; (s) =roots
after senescence; F = fresh material; D =dried material. TLC plates
developed in hexane:ethyl acetate 2:1.
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The senesced leaves showed a loss of photosynthetic pigments compared with the
green leaves, as would be expected. Examples of this can be seen in bands A (R, 0.63)
and B (R, 0.43) which are only present in the first two lanes (extracts from green
material) (Figure 5.2). In the rhizome extracts, the dark band C (R, 0.07), visible under
UV light, was not seen in the a-rhizomes after senescence. However, the white
fluorescing band 0 (R, 0.64) did appear brighter in the a-rhizome extracts (Figure 5.3).
The main difference observed in the root extracts appeared to be an increase in the
compound seen in band E (R, 0.74) in the a-rhizomes after senescence (Figure 5.4) .
Although minor differences were observed in the TLC analysis of the various extracts
prepared, it is not possible to conclude whether these changes are in any way related
to changes in activity. However, TLC fingerprinting does provide a simple method of
illustrating differences in the chemical composition of plant extracts. For quantitative
analysis of TLC fingerprints it is important to employ consistent extraction methods,
even loading of the extracts on the TLC plate and replicable development systems.
5.3.2 CQX-1 inhibition by S. aethiopicus extracts
Results for the study of seasonal effects on CQX-1 inhibition are shown in Figure 5.5.
As observed with the initial screening (see section 2.3.3), the leaves showed the highest
levels of activity, with the exception of senesced leaf material that was dried prior to
extraction. No differences were observed between the activity of the a- and~­
rhizomes, before and after senescence. For the a-roots, there was a slight decrease
in activity following senescence. This was seen in both the fresh and dried material.























Figure 5.5 CQX-1 inhibitory activity (± SO) of ethanol extracts of various plant parts
of S. aethiopicus before and after senescence. Extracts were tested at a
final concentration of 250 I..Jg rnl' per test solution. Values represent the
mean of double determinations from two experiments. The indomethacin
standard inhibited the synthesis of prostaglandins by 54 ± 5.7%.
5.3.3 Antibacterial activity of S. aethiopicus extracts
Results forthe study of seasonal effects on antibacterial activity are shown in Table 5.1.
Little difference was observed between the extracts prepared from fresh and dry
material for activity against S. aureus. Extracts prepared from the leaves gave a MIC
value of 0.2 (fresh) and 0.1 (dry) mg rnl' before senescence and 3.13 mg rnl' after
senescence, indicating a loss in activity. ' Extracts prepared from a-roots gave MIC
values of 3.13 and 1.56 mg ml' before senescence and 0.1 and 0.2 mg ml' after
senescence, indicating an increase in activity.
Table 5.1
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Minimum inhibitory concentrations (mg rnl') of S. aethiopicus ethanol
extracts against S. aureus.
The method of drying plant material at temperatures of 40-50 "C can cause the
breakdown of certain compounds or a change in the concentration of volatile
components, leading to a potential loss of activity. It is therefore important to consider
the effects of the preparation method and storage on the biological activity of medicinal
plants. Although fresh material may be more pharmacologically active, dried material




• S. aethiopicus plants were harvested before senescence and after senescence.
Ethanol extracts were prepared from fresh or dried material of the leaves,
rhizomes and roots, and tested in the CQX-1 assay and the microdilution
antibacterial assay.
TLC fingerprints of the extracts were prepared.
• No noteworthy changes in CQX-1 inhibition, due to senescence, were observed
from extracts prepared from fresh material.
• There appeared to be a slight decrease in CQX-1 inhibition with the a-roots and
an increase in the ~-roots after senescence.
• A decrease in antibacterial activity of the leaves after senescence was observed .
An increase in antibacterial activity of the a-roots was observed after
senescence.
• The time of harvest, and the effect of drying plant material, may only have a




Within the plant kingdom there is great potential for the discovery of biologically active
natural products forthe development of new effective therapeutic agents (BALANDRIN,
KINGHORN and FARNSWORTH, 1993). The discovery of biological activity and the
subsequent isolation of active principles are necessary first steps in the drug
development process (COX and BALlCK, 1994). Successful research in this field
requires a rigorous and methodical multi-disciplinary approach, incorporating analytical
chemistry, bioactive compound discovery, bioassay method development, clinical
studies, cultivation of medicinal plants, ethnobotany , organic synthesis , pharmacology ,
phytochemistry , the standardization of traditional medicines, taxonomy, tissue culture,
and numerous other disciplines (KINGHORN, 2001).
Although the goal of modern therapeutic phytochemistry is the discovery of new active
principles and their improvement, the use of plants and plant extracts will continue in
traditional medicinal systems. It is important, however, to evaluate the safety and
efficacy of plants used in traditional medicine.
In South Africa, there is a need for systematic documentation of traditional plant use and
the evaluation of the medicinal plants used in traditional medicine (VAN WYK, 2002) .
Furthermore, with the increasing problem of HIV infection, there is a need for
therapeutic agents which can be used against opportunistic infections related to AIDS.
The emerging problem of bacterial resistance to drugs also necessitates the discovery
and development of novel antibacterial agents.
The results presented in this thesis provide an example for approaching investigations
of medicinal plants, including pharmacological screening of plant extracts, followed by
bioassay-guided fractionation leading to the isolation of pure constituents
(HOSTETTMANN, MARSTON and WOLFENDER, 1995). The first aspect of the
investigation comprised the testing of extracts from the different parts of S. aethiopicus
for in vitro anti-inflammatory activity in the COX-1 and COX-2 assays, and for
antibacterial activity in the microdilution assay. The isolation and identification of a
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compound showing activity in a bioautographic assay was also conducted using various
chromatographic and spectroscopic techniques.
The final part of the investigation involved testing for COX-1 inhibitory activity and
antibacterial activity of S. aethiopicus plants before and after senescence to determine
if senescence has any effect on the medicinal properties of the plant. Minimal
differences were observed between green and senesced plants, which suggests that
plants could be harvested at either stage. However, the roots of fully senesced plants
decay during the winter, and thus it would be more useful to harvest plants which still
have healthy roots.
This thesis also provides a starting point for future , more detailed studies on S.
aethiopicus, as an investigation of this nature cannot fully evaluate all aspects of the
medicinal properties of the plant. Activity against CQX-1 and CQX-2 can be evaluated
further for the potential isolation of active compounds. The bioautographic assay
showed a number of antibacterial zones which can be further investigated, leading to
the possible isolation of active principles.
Extracts from S. aethiopicus have also been screened for activity in a number of other
bioassays in a further investigation of the pharmacological properties of the plant. No
activity was observed in a simple anthelmintic bioassay, using Caenorhabditis elegans
free-living nematodes as test organisms, and in an antischistosomal bioassay.
Furthermore, no significant activity against the herpes simplex virus types 1 and 2, and
the influenza A virus were observed . However, some cytotoxicity was observed with the
aqueous extracts of the rhizome, indicative of potential harm (LIGHT, McGAW, RASE,
SPARG, TAYLOR, ERASMUS , JAGER and VAN STADEN, 2002). This is one aspect
which certainly requires further investigation.
S. aethiopicus represents a valuable indigenous resource which has potential for future
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APPENDIX 1: Medicinal uses of the Zingiberaceae
Plants of the Zingiberaceae, their occurrence and medicinal uses (JOHNSON, 1999).
Species name Distribution Action Used to treat













Egypt, Ghana, Liberia, Nigeria
USA, India, Java, Turkey
Java
USA, East Indies, Egypt, India,
Southeast Asia, Turkey
Haleakala National Park, Hawaii,
Volcanoes National Park, Samoa























Species name Distribution Action Used to treat
Alpinia speciosa Dominica , Haiti diuretic common cold, fever, flatulence, flu,
indigestion
Amomum aromaticum
Amomum cardamom Europe sclerosis (uterus)





Amomum gracile Serkkom dyspepsia, nausea
Amomum granum-paradisi Europe tumor (liver)
Amomum hochreutineri Kihitir lumbago
Amomum kepulaga Malaya common cold, cough, halitosis,
hepatosis, insanity, rheumatism
Amomum krevanh Cambodia tumor (uterus)
Amomum melegueta Gabon, Trinidad antispasmodic, carminative, cancer (nose) , colic, common cold ,
pectoral dyspepsia , fever, stomach ache
Amomum sp. Philippines cough
Amomum squarrosum Malaya giddiness
Amomum subulatum Nepal stomachic neuralgia






















Egypt, Haiti, Hawaii , India, Japan,
















to alleviate pain after childbirth
asthma, cough, dermatosis,
insanity, parturition, scabies , scurf
contusion , sprains





cancer, carbuncles, chills, cholera,
common cold, conjunctivitis,
consumption, cough, depurative,
dermatitis, dyspepsia, fever , fistula,
gall, hepatitis , hypotherbia , hysteria,
inflammation, insect bites, jaundice,
lockjaw, ophthalm ia, parturition,
pimples, polyps, prolapse ,
puerperium, rash, rhagades,
rheumatism, scabies, slurring, sore,






Species name Distribution Action Used to treat
Curcuma /onga Asia, Haleakala National park, balsamic, diuretic, lactogogue, abscesses, amenor rhea, athlete's
Java, Malaya, Nepal, Philippines stomachic, tonic, urogenital, foot, common cold, conjunctivitis,
vulnerary depurative, dermatosis, diarrhoea,
dysentery, gonorrhea, gravel ,
hepatosis, impetigo , jaundice,
parturition, pyuria, rashes of infants,
scabies , skin sores, sore, swelling,
wounds
Curcuma mangga Java, Malaya stomachic fever
Curcuma pallida Vietnam cancer (stomach)
Curcuma petio/a ta Java, Vietnam synergist cancer (stomach)
Curcuma purpurascens Koenengpengang, boils, cough , fever , itch, scabies,
Koenengtinggang wounds
Curcuma sp. Great Britain tumor (belly) , wen
Curcuma xanthorrhiza Java, Singapore choleretic, emmenagogue amenorrhea, constipation,
dyspepsia, gallstones, hepatosis,
parturition, rheumatism
Curcuma zeodoaria Egypt, Iran, Java, Malaya antidote, carm inative, stomac hic, bruises, conva lescence, dyspepsia,
tonic parturition, sprains, tumor
Curcuma zerumbet
E/ettaria cardamomum Cambodia , Egypt, India, Sri Lanka , aromatic, carminative, digest ive, asthma, bronchitis, consumption,
Turkey diuretic, stimulant, stomachic cough , flatulence, indigest ion,
phthisis, tumor (uterus)
E/ettariopsis sp. Malaya parturition
E/ettariopsis sumatrana Sumatra scorpion sting



























Haleakala National Park, Hawaii,
India, Indonesia, Java, Kalaupapa
National Historic Park, Moluccas
Haleakala national Park, Hawaii
Volcanoes National Park,
Kalaupapa National Historic Park






Asia, India, Java, Malay, Malaysia,
















halitosis , rhinitis, sore throat,





cancer, cough, dandruff, dyspepsia,
eye infection, fever, headache,
malaria, mastitis , ophthalmia,





Species name Distribution Action Used to treat
Kaempferia pandurata
Kaempferia pulehra
Kaempferia rotunda Java, Malaya stomach ache
Kaempferia sp. Great Britain wen
Languas eannifolia Malaya fever
Languas eonehigera Malaya ostealgia, parturition, rheumatism
Languas maJaeeensis
Languas mutica Penang stomachic
Languas rafflesiana Malacca boils
Languas seabra Perak vertigo
Languas sp. Malaya pediculicide
NieoJaia speeiosa Java, Malaya deodorant earache, wounds
Phaeomeria magnifiea Malaya spice
Renealmia antillarum Dominican Republic, Haiti diuretic rheumatism
Renealmia aromatiea Guatemala, Panama deodorant inflammation
Renealmia eernua Panama fever, typhoid
Renealmia domingensis Brazil, Mexico emmenagogue piles
Renealmia exaltata Brazil, Trinidad antiseptic cancer, depurative, marasmus,
sore, sprains, swelling
Renealmia oeeidentalis Venezuela resolvent excrescence, tumor








































ague, anasarca, anemia , anthrax ,
ascites , asthma, bronchitis , colic ,
const ipation , cramps, dropsy, fever,
flatulence, gonorrhea, headache ,
jaundice, malaria , numbness ,
partur ition, phthisis , stomach ache
fever















USA, Asia, Burkina Faso, China,
Dominican Republic, Egypt,
Ethiopia, Great Britain, Haiti, India,
Indonesia, Java, Malay, Mexico,
New Guinea, Philippines, Trinidad,




Asia, Egypt, Fiji, Haleakala
National Park, Hawaii, India, Java,
Kalaupapa National Historic Park,
nature Preserve of American
















diarrhoea, dog bites, dysentery,
dyspepsia, fatigue, fever, fistula,
flatulence, flu, gingivosis, gout,
head colds , headache, hepatosis,
indigestion, infection, intestinal gas,




rheumatism, rhinosis, snake bite,
sore, stomach ache, suppressed
menstruation, swelling, syphilis,







burns, cough, dermatitis, diarrhoea,
dysentery , dysuria. gallstones,
gonorrhea, headaceh, lassitude,
leprosy, mouth infection, peptic
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